"Moon-like" face (Cushing's syndrome)
11C-labelled metomidate PET
13-cis-retinoic acid (isotretinoin)
131I-mIBG (meta iodo benzyl guanidine) (for metastatic disease)
24-hour urine levels of 5-HIAA (5-hydroxyindoleacetic acid)
3' APC mutation (for FAP patients)
3D conformal radiation therapy
5-fluorouracil with leucovorin
5-FU (Fluorouracil)
A cough that doesn't go away or gets worse
A lump in the abdomen
A lump in the neck
A sore throat that does not go away
Abdominal (belly) pain
Abdominal fullness
Abdominal lymphadenopathy
Abdominal mass or swelling
Abdominal organ leiomyosarcoma
Abdominal pain (due to intestinal blockage)
Abdominal pain (liver metastases)
Abdominal pain or swelling
Abdominal pains (if in the abdomen)
Abdominal swelling
Abdominal swelling (ascites due to liver metastasis)
Abdominal swelling (ascites)
Abdominal swelling (ascites, due to liver metastasis)
Abdominal wall desmoid tumor
Ablation (cold, heat, ultrasound)
Ablation therapy (percutaneous ablation, radio frequency ablation, microwave ablation, ethanol injection, acetic acid injection, cryotherapy)
Abnormal appearance of the retina (leukocoria)
Abnormal BCR-ABL protein (tyrosine kinase) leading to uncontrolled cell growth
Abnormal cell growth
Abnormal cells in the vagina, cervix, or uterus
Abnormal cells that invade or spread to other parts of the body
Abnormal conception with excessive placental development
Abnormal DNA methylation of tumor suppressor promoters
Abnormal feeling in the legs (spinal tumor)
Abnormal growth factor signaling
Abnormal growth of endometrial cells
Abnormal liver function tests (e.g., elevated bilirubin, alkaline phosphatase, gamma glutamyl transferase)
Abnormal menstrual cycles (before menopause)
Abnormal migration of germ cells during embryogenesis
Abnormal T cell or B cell development (for non-Hodgkin lymphoma)
Abnormal T cells or B cells
Abnormal TAZ-CAMTA1 fusion protein variant that is constitutively active
Abnormal testicle development
Abnormal uterine bleeding (ovarian)
Abnormal uterine bleeding (postmenopausal patients)
Abnormal vaginal bleeding
Abnormal vaginal bleeding (after sex, between menstrual periods, after douching, after pelvic exam, heavy bleeding)
Abnormal vaginal bleeding after menopause
Abnormalities affecting Wnt signaling pathway, cell cycle regulation, RNA metabolism, protein folding, and cadherin-related cell adherence
Absence of FUS-DDIT3 or EWSR1-DDIT3 fusion genes (for myxoid pleomorphic liposarcoma)
Absence of HMB-45 marker (for differentiation from melanoma)
Absence of S100 marker (for differentiation from melanoma)
AC003092.1
Accelerated phase
Accumulation of genetic mutations to the DNA of cells in the prostate
Acetaldehyde (metabolite of alcohol)
Acid reflux (Gastroesophageal reflux disease - GERD)
Acitretin (for people following kidney transplant)
Acne (Virilization)
Acquired aplastic anemia following immunosuppressive treatment
Acquired mutation in CALR gene
Acquired mutation in JAK2 gene
Acquired mutation in MPL gene
Acquired somatic mutations in CTNNB1 gene
Acrylonitrile (in tobacco smoke)
Actinomycin D (chemotherapy drug)
Activation of the MYB oncogene
Active surveillance (for rectal cancer)
Acute abdominal pain (if tumor ruptures)
Acute central venous thrombosis
Acute megakaryoblastic leukemia (rare association)
Acute respiratory symptoms (after pregnancy)
Adenocarcinoma not otherwise specified (NOS)
Adenoidal BCC
Adenoma-carcinoma sequence (polyp to cancer progression)
Adenomatoid
Adenosquamous adrenocortical carcinoma
Adjusting dose or switching immunosuppressive medications (for iatrogenic KS)
Adjuvant chemotherapy (platinum-based)
Adjuvant systemic medical therapy
Adjuvant therapy (chemotherapy after radiation)
Adoptive cell transfer (ACT) using tumor-infiltrating lymphocytes (TILs)
Adoptive transfer of genetically altered autologous lymphocytes
Adrenal tumors (adrenomedullary tumors)
Adriamycin
Adult T-cell lymphoma
Adulthood (for high-grade types)
Aerobic physical exercise
Affected verbal communication
Affects tendons and aponeuroses
Aflatoxin exposure
Aflibercept
AFP level greater than 500 ng/ml
African American ethnicity
African American ethnicity (appears to be affected more often)
African cutaneous Kaposi sarcoma
African-American ethnicity
Age (10-19 years for Osteosarcoma and Ewing's sarcoma)
Age (21-30 years)
Age (30-60 years old)
Age (5-10 years)
Age (early adulthood 20-39, late adulthood 65+)
Age (most common in men between 20 and 39, but can occur at any age)
Age (most often between 60 and 70)
Age (over 40 years for Chondrosarcoma)
Age (peaks at 5 years and 35 years)
Age (under 5 years old)
Age 60 or older
Age between 25 and 65
Age over 30
Age over 40
Age over 50
Age over 80
Age range 20-40 years (typical occurrence)
Age-related abnormal methylation
Ages 5-15 (for bacterial tonsillitis)
Aggressive excision (including thyroid and surrounding tissues if necessary)
AIDS (possible link)
AIDS-associated Kaposi sarcoma
Air pollution
AL102 (investigational)
Alcohol consumption (excessive drinking)
Alcohol consumption (increases risk of sunburns)
Alcohol intake
Alcohol use
Alemtuzumab (Campath)
Alitretinoin (topical)
Alpha-adrenoceptor blockade (doxazosin, prazosin, terazosin, phenoxybenzamine)
Alpha-fetoprotein (AFP) blood levels
Alterations in NF1 gene
Alterations to genes such as WT1
Alterations to genes such as WT2
Alterations to WT1 gene
Alterations to WT2 gene
Altered DNA repair functions in inflammatory bowel disease patients
Alternating electric field therapy
Amaurotic cat's eye reflex
Amphinex
Amputation of the affected limb
Amputation of the extremity
Anabolic steroid abuse (associated with benign tumors transforming)
Anal Pap smears (for screening high-risk individuals)
Anaplastic astrocytoma (WHO Grade III)
Anaplastic thyroid cancer
Anaplastic/malignant (Grade III)
Anasarca (iMCD-TAFRO)
Anatomic imaging (CT, MRI)
Androgen receptor
Androgen receptor (AR) testing
Androgen receptors
Anemia (especially over 50)
Anemia (low RBC count or reduced hemoglobin)
Anemia-like symptoms
Aneurysmal bone cyst (benign)
Annexin A1 and BRAF V600E mutant protein testing
Anoscopy (using an anoscope)
Anovulation (reproductive age patients)
Anti-interleukin-6 (IL-6) therapy (for UCD with inflammatory syndrome, first-line for iMCD)
Antibiotics (for bacterial infections)
Antibiotics (pre-surgery)
Antibodies to the acetylcholine receptor
Anticholinergic medications
Anticonvulsant medication (anti-epileptics for seizures)
Anticonvulsants
Anticonvulsants (if seizures occur)
Antiemetics
Antiestrogens (e.g., tamoxifen)
Antiprogestin agents
Antipsychotic drugs
Antiretrovirals (lamivudine, doravirine, cabotegravir)
Antithyroid antibody measurement
Antiviral drugs
Antivirals (for HHV-8-associated MCD)
Appearance of a new mole during adulthood (melanoma)
Appetite-increasing drugs (megestrol acetate, corticosteroids)
Arise from various neuroendocrine cells
Arrhythmia (during carcinoid crisis)
Artificial UV radiation (tanning beds)
Ascites
Ascites (fluid buildup in the abdominal cavity)
Ascites (fluid in the abdomen)
Ascitic drain
Ashkenazi Jewish descent
Ashkenazi Jewish ethnicity (due to APC gene mutations)
Asian ethnicity (for general thyroid cancer)
Asian ethnicity (for upper throat cancer)
Assessment for cellular atypia and stratification
Association with vascular endothelial growth factor
Asthma or wheezing
Asymmetric testicular enlargement
Asymptomatic (can be)
Asymptomatic (mass identified on imaging)
Asymptomatic (most common)
Asymptomatic at diagnosis (often advanced at diagnosis)
ATM mutations
Atrophic DFSP
ATRX mutations
Atypical (Grade II)
Atypical carcinoid (AC)
Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL)
Auditory brainstem response test (ABR)
Autoimmune deterioration of cerebellum, limbic system, or brainstem
Autoimmune diseases (e.g., lupus erythematosus)
Autosomal dominant familial isolated hyperparathyroidism
Awkward gait patterns
Back or bone pain
Bad breath
Balance problems
Balanced, reciprocal translocation t(1;3)(p36.3;q25)
Barium swallow or barium meal
Barium swallow/meal
Basal Cell Carcinoma (eyelid)
Basal-cell nevus syndrome (Gorlin syndrome)
Basal-cell skin cancer (BCC)
BCD (bleomycin, cyclophosphamide, dactinomycin)
BCG vaccine (intravesical)
BCR-ABL1
Bednar tumor (Pigmented DFSP)
Behavioral changes (e.g., inappropriate social behavior, personality changes, temper tantrums, lower inhibition)
Being a woman
Being a young man in Africa
Being Asian
Being Black (tend to have greater severity and worse survival)
Being extremely pale
Being female
Being female (solitary glomus tumors, especially subungual lesions)
Being male (in children)
Being male (multiple lesions)
Being overweight
Being shaky
Being underweight
Being White
Bence Jones protein test (urine)
Benign (Grade I)
Benign epithelial tumours
Benign mucinous tumors
Benign serous tumors
Benign tumors
Beta-adrenoceptor blockade (atenolol, metoprolol, propranolol)
Beta-catenin mutations
Betel nut chewing
Bevacizumab (anti-VEGFA antibody, for cerebral edema)
Bexarotene (Targretin)
bFGF
Bilateral Babinski sign
Bilateral lower leg swelling
Bilateral prophylactic salpingo-oophorectomy (for BRCA carriers)
Bilateral salpingo-oophorectomy (removal of ovaries and fallopian tubes)
Bilateral tonsillectomy
Bilateral VS (associated with Neurofibromatosis Type 2)
Bilateral Wilms' tumor
Bile reflux (unconjugated bile acids inducing oxidative stress and DNA damage)
Bile reflux (unconjugated bile acids)
Bilious vomit
Biochemical evaluation (elevated plasma free metanephrines)
Biologic immunotherapy agents (e.g., ipilimumab, pembrolizumab, nivolumab, cemiplimab)
Biologic therapies
Biological therapy (immunotherapy)
Biopsies
Biopsies of peritoneal fluid
Biopsy (core needle biopsy, open biopsy)
Biopsy (core needle or surgical incision)
Biopsy (CT-guided needle biopsy, histologic examination)
Biopsy (examination of cells/tissue under microscope)
Biopsy (fine needle aspiration)
Biopsy (for microscopic inspection)
Biopsy (histological examination)
Biopsy (histological proof of cancer type and grade)
Biopsy (implied for tissue examination)
Biopsy (including lymph node biopsy)
Biopsy (lymph node biopsy, bone marrow testing)
Biopsy (lymph node or bone marrow)
Biopsy (needle aspiration or surgical)
Biopsy (needle or open)
Biopsy (orthopedic oncologist for non-facial, oral & maxillofacial surgeon for facial)
Biopsy (risk of spreading)
Biopsy (tissue sample examination)
Biopsy (tumor tissue removal)
Biopsy (with histopathologic and immunohistochemical analysis)
Biopsy for histological examination
Biopsy of fallopian tissue
Biopsy of observed abnormal tissue
Biopsy of skin lesions
Biopsy of suspicious tissue
Biopsy of the lung
Biopsy of the tumor
Biopsy of tissue (during surgery)
Biopsy of tissue (often during surgery)
Biopsy or cell collection for microscopic examination
Biopsy or cell collection for microscopic examination (head and neck cancer)
Biopsy or other procedure to collect cells for microscopic examination
Birth defects
Bispecific T-cell engagers (BITE)
Bisphosphonates (for bone density/loss)
Black discolouration of stool (melena)
Black ethnicity
Black or black-blue area in a mole
Black women (for leiomyosarcoma)
Bladder cystoscopy
Blastic phase (Blast crisis)
Bleeding (cutaneous)
Bleeding after menopause
Bleeding between periods
Bleeding from a mole
Bleeding from the anus or rectum
Bleeding from the mouth
Bleeding from the penis
Bleeding from the urethra
Bleeding gums
Bleeding that is longer than normal
Bleeding that is not your period
Bleeding, pain, or numbness in the lip or mouth
Bloating of the stomach after meals
Blood and urine tests
Blood and/or urine tests
Blood and/or urine tests (head and neck cancer)
Blood chemistry studies
Blood chemistry tests
Blood chemistry tests (BMP, CMP, electrolyte panel)
Blood chemistry tests (e.g., basic metabolic panel, comprehensive metabolic panel, kidney function tests, liver function tests, electrolyte panel)
Blood chemistry tests (e.g., Basic Metabolic Panel, Comprehensive Metabolic Panel, kidney function tests, liver function tests, electrolyte panel)
Blood clots (Trousseau's syndrome)
Blood clots in legs (due to blocked pelvic veins)
Blood Count Tests
Blood counts
Blood film analysis
Blood in sputum (hemoptysis)
Blood in stool (melena)
Blood in the stool (bright red or very dark)
Blood in the stool (melena)
Blood in the urine
Blood in urine
Blood in urine (haematuria, visible or microscopic)
Blood in urine or semen
Blood or bone marrow stem cell transplants (hematopoietic stem cell transplantation)
Blood smear examination (presence of hairy cells with characteristic projections)
Blood test checking alpha-fetoprotein (AFP) level
Blood tests
Blood Tests
Blood tests (CA-125, CBC)
Blood tests (CA-125, HE4, alpha-fetoprotein, hCG, inhibin A/B, lactate dehydrogenase)
Blood tests (calcitonin, CEA, metanephrines)
Blood tests (complete blood count, fecal occult blood test)
Blood tests (e.g., complete blood count - CBC)
Blood tests (e.g., protein electrophoresis, serum free light chain assay)
Blood tests (e.g., serum CEA, CA19-9, liver function tests)
Blood tests (for EBV titers)
Blood tests (including tumor markers like alpha-fetoprotein, human chorionic gonadotropin, and LDH-1)
Blood tests for tumor markers (carcinoembryonic antigen, carbohydrate antigen)
Blood tests to eliminate other causes of cytopenias
Blood tests to rule out other conditions
Blood transfusions (for low red blood cells or platelets)
Blood-stained watery vaginal discharge
Bloody penile discharge
Blue light cystoscopy (with hexaminolevulinate dye)
Bluish discoloration
Blurred or double vision
Bone abnormalities
Bone dysplasias (Paget's disease of bone, fibrous dysplasia, enchondromatosis, hereditary multiple exostoses)
Bone fracture (pathologic fracture)
Bone fractures
Bone lesions (rare, in recurrent disease)
Bone marrow biopsy (confirmation of HCL infiltration and absence of other diseases)
Bone marrow examination
Bone marrow failure (thrombocytopenia, anemia, leukopenia)
Bone marrow or stem cell transplant (not explicitly mentioned for ovarian cancer, but a general cancer treatment)
Bone Marrow Test
Bone modifying agents (zoledronic acid, denosumab)
Bone pain (distant spread)
Bone pain (often in the back or ribs)
Bone scan (for metastasis evaluation)
Bone scintigraphy
Bone trauma and microfractures
Bone weakening and fractures (bone metastases)
Bone weakness (increased fracture risk)
Bone-strengthening agents (denosumab, bisphosphonates)
Borderline mucinous tumors
Borderline serous tumors
Borderline tumors (low malignant potential - LMP)
Boron neutron capture therapy (experimental)
Bortezomib (under investigation)
Bortezomib-based induction regimen
Bowel problems
Bowel resection
Brachyury
Brackens consumption
BRAF 600E
BRAF inhibitors (e.g., dabrafenib, vemurafenib)
BRAF inhibitors (e.g., vemurafenib, dabrafenib)
BRAF mutant subtype
BRAF V600E
Brain swelling
BRCA-1/BRCA-2 mutations
BRCA1 gene changes
BRCA2 gene changes
BRCA2 mutations
Breast biopsy (core needle biopsy, fine-needle aspiration)
Breast enlargement (gynecomastia)
Breast enlargement (in men, Feminization)
Breast feels harder or firmer
Breast size may seem to decrease
Breast-conserving surgery
Breath test (experimental)
Breathing problems
Breathlessness
Breslow scoring
Bronchial carcinoids
Bronchoscopy (for lungs)
Bronchoscopy with biopsy (for pulmonary tumors)
Bronchospasm (during carcinoid crisis)
Bronchus NETs
Bruise-like appearance (cutaneous)
Bruising
Bulging eyes
Bumps that are not painful or itchy (Merkel cell carcinomas)
Burning or tingling while urinating (dysuria)
C-Met
c-Met
c-Myc
c-myc
CA-125 blood test
CA-125 tumor marker test
CA19-9 levels
CA19-9 tumor marker
Cachexia (loss of appetite, weight loss, fatigue)
CAIX
Calcimimetics (e.g., cinacalcet) to lower calcium levels
Calcium-channel blocker (amlodipine)
Canalicular adenoma
Cancer cells blocking lymph vessels in the skin of the breast
Cancer immunotherapy (head and neck cancer)
Cancer of the bile duct inside the liver
Cancer of the bile duct outside of the liver
Cancer staging (TNM system)
Cancer vaccines
Cancer vaccines (Hepcortespenlisimut-L)
Cancerous cell population in POEMS syndrome producing cytokines (POEMS-associated Multicentric Castleman disease)
CAR-T cell therapy
Carcinoembryonic antigen (CEA) blood level measurements
Carcinoid tumors
Carcinoid tumors (Neuroendocrine tumors)
Carcinoma in situ (Stage 0)
Carcinoma of the collecting ducts of Bellini
Carcinomasarcoid variant
Cardiac symptoms (constrictive pericarditis, heart failure, pulmonary embolism, cardiac tamponade)
Carney complex (CNC)
Carotene deficiency
Carotid paraganglioma (carotid body tumor)
Cartilage tumors (WHO 2020 classification)
Cartilaginous and osseous metaplasia
Castration-resistant prostate cancer (CRPC)
Caucasian ethnicity
Caucasian ethnicity (minor prevalence for neuroendocrine tumors)
Caveolin 1
Caveolin 2
CCPDMA
CD31 marker (gold standard)
CD34 marker
CDKN2A (p16)
CDKN2A (p16) mutations
CDKN2B (p15)
CDX2
Celiac disease (slightly increased risk)
Celiac plexus nerve block
Cellular progression from hyperplasia and metaplasia to dysplasia and carcinoma
Central diabetes insipidus (severe thirst, excessive dilute urine)
Cerebrospinal fluid (CSF) examination
Certain genetic conditions
Certain genetic conditions (e.g., multiple endocrine neoplasia)
Certain genetic diseases
Certain genetic diseases (general for soft tissue sarcomas)
Certain hereditary disorders
Certain imaging tests such as CT scans
Certain occupations (firefighting, hairdressing, agricultural and industrial work)
Certain strains of H. pylori
Certain types of infections
Cervical biopsy (tissue sample removal for microscopic examination, e.g., punch biopsy)
Cervical conization (cone biopsy) (for severe precancerous lesions or diagnosis)
Cervical inflexibility
Cervical screening (Pap test, HPV test)
Cessation of menstruation (Virilization)
Change in appetite
Change in bowel habits (diarrhea, constipation, narrower stool)
Change in bowel habits (e.g., narrower stools, increased frequency, bowel incontinence)
Change in bowel movements
Change in breast size or shape
Change in how the testicle feels
Change in mole size (usually increase)
Change in size, shape, color, or feel of a mole
Change in the size or shape of the breast
Change in the size, shape, color, or elevation of a mole (melanoma)
Change or hoarseness in the voice
Change or hoarseness in the voice (head and neck cancer, not glomus tumor)
Changes in ability to talk, hear, or see
Changes in breathing
Changes in existing moles (size, shape, color, irregular edges, bleeding, itching)
Changes in existing moles (size, shape, color, irregular edges, more than one color, itchy, bleeds)
Changes in genes (gene variants or mutations)
Changes in genetic material (DNA)
Changes in HOXA13 expressing compartment
Changes in mood or behavior
Changes in taste
Changes in the color of the skin of the vulva (redder or whiter)
Changes in the genetic material (DNA) in bone marrow cells
Changes in the skin that do not heal
Changes in the vulvar skin (color changes, growths, ulcer)
Changes to mood or concentration
Changes to the DNA of bladder cells
Characteristic abnormal lymph node features (e.g., plasmacytic, hyaline vascular, hypervascular, mixed features)
Checkpoint inhibitors
Chemoradiation
Chemoreduction
Chemotherapeutic cyclophosphamide
Chemotherapy (anthracycline, Ifosfamide, gemcitabine, paclitaxel, dacarbazine)
Chemotherapy (BEP regimen: bleomycin, etoposide, cisplatin)
Chemotherapy (cisplatin with etoposide, doxorubicin with streptozocin, fluorouracil)
Chemotherapy (cisplatin, carboplatin, oxaliplatin, fluorouracil (5-FU), capecitabine, epirubicin, nivolumab, pembrolizumab)
Chemotherapy (cisplatin, pemetrexed, raltitrexed, gemcitabine, vinorelbine, carboplatin)
Chemotherapy (cisplatin, pemetrexed, raltitrexed, gemcitabine, vinorelbine, carboplatin, adriamycin)
Chemotherapy (cisplatin, vincristine, methotrexate)
Chemotherapy (currently not effective)
Chemotherapy (cyclophosphamide, doxorubicin, cisplatin)
Chemotherapy (cyclophosphamide, vincristine, and dacarbazine - CVD; temozolomide - TMZ)
Chemotherapy (dacarbazine, temozolomide, fotemustine)
Chemotherapy (docetaxel, cabazitaxel, mitoxantrone)
Chemotherapy (e.g., 5-fluorouracil with leucovorin, gemcitabine, cisplatin, irinotecan, capecitabine)
Chemotherapy (e.g., 5-fluorouracil, cisplatin, epirubicin, etoposide, docetaxel, oxaliplatin, capecitabine, irinotecan)
Chemotherapy (e.g., Bleomycin-Etoposide-Cisplatin (BEP), Etoposide-Cisplatin (EP), carboplatin)
Chemotherapy (e.g., cisplatin, carboplatin, oxaliplatin, fluorouracil, capecitabine, epirubicin)
Chemotherapy (e.g., cisplatin-based chemotherapy, combination of hycamtin and cisplatin)
Chemotherapy (e.g., cisplatinum, carboplatinum, cyclophosphamide, vincristine, etoposide, ifosfamide, mafosfamide)
Chemotherapy (e.g., cyclophosphamide, doxorubicin, fluorouracil, paclitaxel, cisplatin)
Chemotherapy (e.g., doxorubicin, ifosfamide, gemcitabine, docetaxel, eribulin, trabectedin)
Chemotherapy (e.g., Fluorouracil (5-FU), Capecitabine, Oxaliplatin, Irinotecan, UFT, CAPOX, FOLFOX, FOLFOXIRI, FOLFIRI regimens)
Chemotherapy (e.g., methotrexate, vinblastine, vinorelbine, doxorubicin)
Chemotherapy (e.g., temozolomide)
Chemotherapy (few cases respond)
Chemotherapy (for invasive mole or choriocarcinoma)
Chemotherapy (for late-stage, highly metastasized cases)
Chemotherapy (for metastatic disease, on a case-by-case basis)
Chemotherapy (gemcitabine, 5-FU, FOLFIRINOX, nab-paclitaxel)
Chemotherapy (head and neck cancer)
Chemotherapy (if clear resection margins not achieved or for advanced disease)
Chemotherapy (in cats, post-amputation)
Chemotherapy (in dogs)
Chemotherapy (limited use, for special cases)
Chemotherapy (multidrug, e.g., vincristine, doxorubicin, cyclophosphamide, ifosfamide, etoposide)
Chemotherapy (postoperative chemotherapy, chemotherapy agents like temozolomide)
Chemotherapy (systemic or regional)
Chemotherapy (systemic therapy for widespread disease)
Chemotherapy alone for inoperable disease
Chemotherapy following guidelines for poor-prognosis testicular cancer (for nonseminomatous tumors)
Chemotherapy using bleomycin, etoposide and cisplatin (for seminomas)
Chemotherapy with Cisplatin
Chemotherapy with Doxorubicin
Chemotherapy with Etoposide (EDP regimen)
Chemotherapy with Mitotane
Chemotherapy with Streptozotocin
Chemowafer implants (experimental)
Chest CT (for metastasis evaluation)
Chest CT scan
Chest or abdominal discomfort
Chest pain (lung metastases)
Chest X-ray
Chest x-ray
Chest X-ray (for lung metastasis)
Chest X-ray (showing lung infiltrates)
Chewing betel nut
Chewing betel quid (paan)
Chewing paan (betel quid)
Childhood exposure to UV radiation (for melanomas and basal-cell cancers)
Childhood or young adulthood (for low-grade types)
Childhood UV light exposure
Children over age two
Chilled sensation
Chills (rare, constitutional symptom)
Chimeric antigen receptor T cell therapies (e.g., lisocabtagene maraleucel, axicabtagene ciloleucel, tisagenlecleucel, brexucabtagene autoleucel)
Chinese or Asian ancestry
Chlamydia pneumoniae infection
Chlamydophila pneumoniae infection
Chlorophyllin (potential for aflatoxin effects)
Cholangiocellular cystadenocarcinoma
Choriocarcinoma (gestational choriocarcinoma, non-gestational choriocarcinoma)
Choroidectomy (removal of choroid layer)
Chromatin remodeling agents (Histone deacetylase inhibitors - preclinical)
Chromogranin A (CgA)
Chromogranin A test
Chromophobe RCC
Chromosomal abnormalities
Chromosomal translocation t(17;22) fusing COL1A1 and PDGF genes, leading to a self-stimulatory growth signal
Chromosomal translocations (e.g., between immunoglobulin heavy chain gene and oncogenes)
Chromosomal translocations (general to hematologic malignancies, arising from aberrant DNA double-strand break repair)
Chromosome 19
Chromosome 19q (loss)
Chromosome 1p (loss)
Chromosome 20q
Chronic bladder infections
Chronic exposure to carcinogenic effects of alcohol and tobacco
Chronic inflammation due to infection
Chronic inflammation of bile ducts
Chronic inflammation of the penis
Chronic inflammation or autoimmunity affecting the vulvar area
Chronic liver disease (including viral hepatitis, alcoholic liver disease)
Chronic liver injury
Chronic lymphedema
Chronic non-healing wounds (Marjolin's ulcers)
Chronic obstructive pulmonary disorder (COPD)
Chronic oral cavity inflammation
Chronic Salmonella typhi infection
Chronic sinusitis (hypothesized)
Chronic viral hepatitis (estimated cause of 80% cases globally)
Chronic vulvar itching or burning
Ciliated cell endometrioid adenocarcinoma
Circadian disruptions related to shift-work and routine late-night eating
Cladribine (purine analog, first-line therapy)
Clark level assessment
Classic basal-cell carcinoma
Classic Hairy Cell Leukemia
Classical
Clear cell adrenal cortical carcinoma
Clear cell RCC
Clear-cell carcinoma
Clear-cell sarcoma
Clear-cell tumors
Clinical characterization
Clinical evaluation for endocrinopathy of characteristic organs
Clinical examination of skin and lymph nodes
Clinical presentation
Clonal eosinophilias
Clonal hypereosinophilias
Clonidine suppression test
Clonorchis sinensis infection
Clostridioides difficile membrane vesicles
Clostridioides difficile strains
Clots in the heart
Coarsening of facial features (Virilization)
Cobimetinib (MEK inhibitor, in combination with BRAF inhibitors)
Coexisting differentiated thyroid cancer (suggests dedifferentiation)
Cognitive difficulties
Cognitive impairment (e.g., problems with thinking, poor reasoning, poor planning, poor memory, difficulty recognizing)
Cold foods
Collision of two independent tumors (Collision tumor hypothesis)
Collision theory (separate tissue types joining)
Colloid cyst
Colposcopy (magnified visual inspection of cervix, often with acetic acid and Lugol's iodine staining)
Combination chemotherapy (for seminomas)
Combination chemotherapy (including Ifosfamide)
Combination theory (stem cell differentiation)
Combinatorial therapy (molecular-based, targeted therapies, immunotherapy, surgery)
Combined modality approach (chemotherapy and radiation)
Combined PET-CT scanning
Combined use of alcohol and tobacco
Commonly found in extremities (knee, feet, ankle)
Compensation strategies (speech, voice, swallow)
Complete blood count
Complete blood count (CBC)
Complete blood count (CBC) showing low white blood cells, red blood cells, and platelets
Complete blood count (CBC) with differential
Complete medical history and physical examination
Complete surgical excision
Complex chromosome and/or gene abnormalities including ring chromosomes, double minutes, deletions, and translocations
Composition theory (adenocarcinoma stimulating stroma)
Compression of vital organs (e.g., intestines, kidneys, lungs, blood vessels, nerves)
Compression or invasion of adjacent structures (lungs, pleura, pericardium, chest wall)
Computed axial tomography (CT)
Computed tomography (CT scan) of the head
Computed tomography (CT) imaging
Computed tomography (CT) scan
Computed tomography (CT) scan (chest, abdomen, pelvis)
Computed Tomography (CT) scan (with iodine-based or barium sulfate contrast)
Computed tomography (CT) scanning
Computed tomography (CT) scanning of the abdomen
Computed tomography (CT) scans
Computed tomography (lobular pattern of the tumor, compartmentalized solid mass with enhancing septa)
Computer-aided analysis (CAD)
Computerized tomography (CT)
Concurrent carboplatin plus paclitaxel
Confirmation of cancer presence
Confusion (Conn syndrome)
Congenital abnormalities of the bile duct (e.g., choledochal cyst)
Congenital infantile fibrosarcoma
Congenital liver malformations (e.g., Caroli disease, choledochal cysts)
Congenital melanocytic nevi syndrome
Congenital mutation in chromosome 13 gene 13q14 (retinoblastoma protein)
Congested sinuses
Consensus molecular subtypes (CMS)
Consolidation/maintenance with immunomodulator agents plus a proteasome inhibitor (e.g., ixazomib, carfilzomib)
Constipation (if in the abdomen)
Constitutive activation of the Wnt signaling pathway
Constitutive activation of YAP
Consumption of hormonal drugs for gender reassignment therapy
Consumption of preserved meats and salted fish containing carcinogenic volatile nitrosamines
Consumption of very hot drinks (over 65 °C)
Continuous cough
Contrast-enhanced computed tomography (CT) scan of the neck
Conventional ependymoma (EPN)
Conventional osteosarcoma (osteoblastic, chondroblastic, fibroblastic)
Conventional radiographs (showing 'moth eaten' pattern, Codman triangle, onion peel appearance)
Convulsions
Copy-number variation within the NBPF10 gene
Corneal light reflex (Hirschberg test)
Corticosteroids (e.g., dexamethasone)
Corticosteroids (e.g., prednisone, prednisolone)
Corticosteroids (for cerebral edema)
Corticosteroids (for critically ill iMCD patients)
Corticosteroids (for increased intracranial pressure)
Cosmetically disfiguring lesions
Cough that doesn't go away
Coughing
Coughing up blood
Coughing up blood (hemoptysis)
CRAB criteria (Calcium, Renal insufficiency, Anemia, Bone lesions)
Cramps
Cranial nerve dysfunction
Cranial nerve palsies (e.g., facial paralysis, abnormal eye movement, swallowing difficulty)
Cranial nerve palsies (e.g., vagus nerve, hypoglossal nerve, spinal accessory nerve)
Criteria for malignancy: tumor size > 2 cm and subfascial or visceral location, atypical mitotic figures, marked nuclear atypia, any level of mitotic activity
Crusting and bleeding in the center of the tumor (BCC)
Crusting and dry ulcer on the lip
Cryoablation
Cryoablation (experimental)
Cryptorchidism (undescended testicles)
CSPG4 (Chondroitin sulfate proteoglycan 4)
CT Angiography (CTA)
CT imaging
CT of the chest and abdomen
CT Scan
CT scan
CT scan (bony anatomy, cortex integrity, pathologic fracture, ossification, calcification)
CT scan (CAT scan)
CT scan (contrast)
CT scan of the neck, chest, abdomen, and pelvis (for staging)
CT scan radiation (up to 4% of brain cancers)
CT scanning of upper urinary tract
CT scans
CT scans (for staging and detecting metastases)
CT scans of abdomen
CT-scans
CTNNB1 (beta-catenin)
CTNNB1 mutation 45F (associated with high risk of recurrence)
Cutaneous myelofibrosis (nodules in skin)
CyberKnife radiotherapy
Cyclical fever (Pel–Ebstein fever)
cyclin E
CYP17
Cytogenetic studies (e.g., Fluorescent in situ hybridization)
Cytogenetics (detecting t(9;22)(q34;q11.2) translocation)
Cytogenetics or chromosomal studies
Cytopathology (examination of fluid produced by cancer)
Cytopathology (examination of fluid)
Cytoreductive surgery (chemically with 131metaiodobenzylguanidine (131I-MIBG))
Cytoreductive surgery (hysterectomy, bilateral salpingo-oophorectomy)
Cytotoxic chemotherapies (for HHV-8-associated MCD, for critically ill iMCD patients)
Dabrafenib (BRAF inhibitor, second-line therapy)
Dactinomycin (chemotherapy drug)
Damage to the DNA of endothelial cells, leading to uncontrolled cell division and inhibited programmed cell death (underlying causes of DNA damage are not fully understood)
Dark circles around the eyes
Dark spot on iris or conjunctiva
Dark urine
DAXX mutations
Deactivation of DCC
Deactivation of SMAD protein
Deactivation of TGF-β
Deactivation of TGF-β and DCC proteins
Death (rarely)
Debulking surgery (for advanced cancer)
Decerebrate attacks
Deciduoid
Decrease in stool caliber
Decreased libido (in men, Feminization)
Decreased range of motion (shoulder)
Decreased sensation in extremities
Decreased vision
Deepening of voice (Virilization)
Deeply situated mass
Deficiency in bile salt export pump (ABCB11 mutation)
Deficiency in certain vitamins
Deformity
Deletion of chromosome 13q14 inactivating the retinoblastoma gene
Deletions in the GLMN (glomulin) gene (familial glomangiomas)
Deletions in the p13 band on chromosome 11
Deliberate exposure of sensitive skin to sunlight
Denileukin diftitox (Ontak)
Dense breast tissue
Dental check-ups (for jaw osteosarcoma)
Dental pain
Dental prostheses
Depressed local immune system (due to sunlight)
Dermatophytes infection
Desmoid tumor of back
Desmoid tumor of buttock
Desmoid tumor of lower extremity and pelvic girdle
Desmoid tumor of the breast
Desmoid tumor of the chest wall
Desmoid tumor of the extremities
Desmoid tumor of the head and neck
Desmoid tumor of the pelvic cavity
Desmoid tumor of upper extremity and shoulder girdle
Desmoplastic small-round-cell tumor
Detection of a pelvic mass on routine gynecologic examination
Detection of DDIT3 gene rearrangements (FUS or EWSR1) by in situ hybridization or immunohistochemistry (for myxoid liposarcoma)
Detection of KSHV protein LANA in tumor cells
Detection of Philadelphia chromosome
Deterioration of vision
Determination of serum levels of alpha-fetoprotein
Determination of serum levels of HCG
Development of excessively high number of genetic abnormalities in plasma cells, precursor B cells, or plasmablasts
Developmental issues (for primary tumors)
Dexamethasone (for swelling/cerebral edema)
Diaphragm stripping or resection
Diarrhea (especially with liver metastasis)
Diet high in red meat, processed meat, saturated fats, sugar
Diet low in fruit and vegetables
Dietary counseling
Dietary factors (fried foods, processed meat, red meat, brackens)
Dietary factors (pickled vegetables, fried foods, smoked foods, salt-rich foods, meat, processed meat, red meat)
Dietary iodine deficiency
Differential diagnosis from Adrenocortical adenoma
Differential diagnosis from Hepatocellular carcinoma
Differential diagnosis from Pheochromocytoma
Differential diagnosis from Renal cell carcinoma
Differential diagnosis from seminoma, teratocarcinoma, yolk sac tumor, and Sertoli–Leydig cell tumor
Differentiated thyroid cancer
Differentiation of borderline tumors from malignant tumors based on clear stromal invasion
Difficult or painful bowel movements
Difficult or painful swallowing
Difficult or painful urination
Difficulty controlling the voice
Difficulty drawing
Difficulty focusing
Difficulty in moving the extremity with the tumor
Difficulty opening mouth widely
Difficulty swallowing (dysphagia)
Difficulty with breathing
Digital rectal exam
Digital rectal exam (DRE)
Dilation and curettage (D & C)
Dimple or puckering in breast skin (orange peel-like texture)
Dimpled or puckered skin
Dimpling or puckering of breast skin ('orange peel' appearance)
Dioxins exposure
Diplopia (double vision)
Discharge from the anus
Discharge from the urethra
Discolored patches that persist in the mouth
Discolored skin
Disorders of nerves, muscles, blood vessels, and blood clotting mechanisms
Dispermic fertilization of a normal ovum (partial hydatidiform mole)
Dispermic fertilization of an empty ovum (complete hydatidiform mole)
Disrupted BMP signaling pathway
Disrupted MYC signaling pathway
Disrupted Notch signaling pathway
Disrupted TGF-β signaling pathway
Distension (liver-related)
Distinct bruising and swelling around the eyes
Distinct genetic alteration
Disturbances in the gut microbiome
Divergent differentiation from a common pluripotential stem cell (Combination hypothesis)
Diverticula of the urethra
DNA analysis (diploid vs. aneuploid, S phase percentage)
DNA damage from UV light exposure
DNA methylation profiling
DNA mismatch repair gene mutations (MLH1, MSH2, MSH6, PMS2, EpCAM) (associated with Lynch syndrome)
Double vision (diplopia)
Down regulation of Cxcl3
Drenching night sweats
Drinking alcohol
Drug therapy
Dry cough
Dry mouth
Dry mouth (xerostomia)
Dull ache in the lower abdomen or groin
Dull backache
Dull pain behind the sternum
Duplicated segments of the LMO1 gene
Duplication of the brachyury gene
Duplications in chromosome Xq26.3 including GPR101 gene (X-LAG syndrome)
Dysfunction of the tumor suppressor gene TRC8/RNF139
Dysphagia (difficulty swallowing)
Dysplastic nevus syndrome (familial atypical multiple mole melanoma - FAMMM)
Dysplastic nevus syndrome (FAMMM-PC)
Dyspnea (due to lung metastasis)
Dysregulation of polycomb repressive complex 2 (PRC2)
E-cadherin
Ear exams
Early age of sexual intercourse
Early age of sun exposure
Early alteration in histogenesis with late transformation or degeneration of the epithelial component
Early menarche
Early onset of male characteristics
Early onset of puberty (pre-pubertal patients)
Early-onset colorectal cancer (EOCC)
Eastern European Jewish heritage
Easy bleeding (due to low platelet count)
Easy bruising (blood clotting abnormalities)
Easy bruising or bleeding
Easy irritability
EBV-positive multiple myeloma
Ecchymosis (bruising)
Echocardiogram (with color doppler for carcinoid heart disease)
Ectopic pituitary adenoma
Eczema-like irritation on nipple/areola (Paget's disease)
Edema (swelling)
Edema after surgery
Effects of tumor bulk
eHAE presenting in the pleura
Elderly individuals
Electrical bio-impedance
Electrocautery
Electrochemotherapy with intravenous bleomycin
Electron microscopy for secretory granules
Elevated above the skin surface (nodular melanoma)
Elevated bilirubin
Elevated fecal bile acids (e.g., deoxycholic acid, cholic acid, chenodeoxycholic acid)
Elevated gamma glutamyl transferase
Elevated levels of bile acids (deoxycholic acid, cholic acid, chenodeoxycholic acid)
Elevated serum hCG
Elevated white blood cell count
Elevation of the nail bed
EMACO regimen (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide, Vincristine)
Embolization
Emesis
Emotional instability
Enchondroma (benign)
Endo-anal ultrasound
Endobronchial ultrasound
Endocrine problems
Endocrinological care
Endocrinopathy of one characteristic organ plus a first-degree relative affected by MEN syndrome
Endocrinopathy of two characteristic affected organs
Endocytoscopy
Endometrial biopsy (for uterine serous carcinoma)
Endorectal ultrasound
Endoscopic retrograde cholangiopancreatography (ERCP) with biopsy
Endoscopic stent placement
Endoscopic stenting
Endoscopic therapy (mucosal ablation, radiofrequency ablation, photodynamic therapy, Nd-YAG laser, argon plasma coagulation)
Endoscopy (ERCP, Endoscopic ultrasound)
Endoscopy (esophagogastroduodenoscopy)
Endoscopy (for stomach and intestines)
Endoscopy (gastroscopy)
Endoscopy (head and neck cancer)
Endoscopy (including endoscopic ultrasound)
Enfortumab vedotin (Padcev)
Enlarged cervical lymph nodes
Enlarged liver
Enlarged liver (hepatomegaly)
Enlarged lymph node
Enlarged lymph node on the outside of the neck
Enlarged lymph nodes
Enlarged lymph nodes (around collarbone)
Enlarged lymph nodes around collarbone
Enlarged pelvic lymph nodes
Enlarged spleen
Enlarged spleen (splenomegaly)
Enlarged spleen or liver
Enlargement of clitoris (Virilization)
Enrichment of Clostridia and other pro-inflammatory taxa
Enrichment of Fusobacterium species
Enucleation (removal of the eye)
Enucleation of the eye
Environmental exposure to ionizing radiation
Epidemic (HIV-associated) Kaposi sarcoma
Epidermal radioisotope therapy
Epidermal radioisotope therapy (e.g., 188Re)
Epigenetic alterations
Epigenetic alterations (e.g., abnormal DNA methylation, altered microRNA expression, histone modifications)
Epigenetic modifications (DNA methylation, histone modifications)
Epigenetic reductions of DNA repair enzyme expression
Epigenetic silencing of genes
Epigenetic silencing of MMR proteins
Epigenome-based Classification (EpiC) subtypes
Epithelial ovarian carcinoma
Epithelial Type
Epstein-Barr virus (EBV) infection (for upper throat and salivary gland cancers)
Epstein-Barr virus (rarely, in immunodeficient individuals)
Epstein–Barr virus infection (for Hodgkin lymphoma and some non-Hodgkin lymphomas)
ERBB2 (Her2/neu)
Erdafitinib (Balversa)
Erionite exposure
Erythrocyte sedimentation rate (ESR) test
Erythrostimulating agents (e.g., darbepoetin alfa, erythropoietin)
Esophageal endoscopic ultrasound
Esophageal squamous-cell carcinoma (ESCC)
Esophageal stent insertion
Esophagogastric junctional adenocarcinoma
Esthesioneuroblastoma (olfactory neuroblastoma)
Estrogen and progesterone receptor (ER/PR) test
Estrogen and progesterone receptor test
Estrogen exposure-linked mutations
Estrogen oxidative metabolites causing DNA damage
Estrogen receptor (ER) testing
Estrogen receptor-positive (ER+)
Estrogen-only hormone replacement therapy (HRT) after menopause
Ethanol consumption
ETV6-NTRK3
Euphorbia peplus (experimental topical treatment)
Evacuation of pregnancy (for hydatidiform mole)
Evaluation of loss of normal tissue architecture
Evaluation of photographs for abnormal red eye reflex (e.g., white/yellow dot for retinoblastoma)
Evidence-based diagnostic criteria for UCD (established in 2020)
Evisceration (removal of eye contents)
EWSR1-ATF1
EWSR1-CREB1
EWSR1-CREM
EWSR1-DDIT3
Examination of cells from tumor under microscope
Examination of surgical specimen (pathology)
Examination of the larynx, trachea, and esophagus
Examination of the oral cavity and oropharynx
Examination of the urethra with a cystoscope
Examination of the vulva
Examination under anesthetic (EUA)
Examination with lighted tube-like instruments
Excess body fat
Excess dehydroepiandrosterone (laboratory finding for virilism)
Excess facial and body hair (Virilization)
Excess fluid around lungs (pleural effusion, due to lung metastasis)
Excess serum androstenedione (laboratory finding for virilism)
Excess serum estrogen (laboratory finding for feminization)
Excessive alcohol consumption (indirectly via chronic pancreatitis)
Excessive estrogen exposure
Excessive growth of facial hair (hirsutism)
Exenteration (removal of eye and orbital contents, potentially eyelids)
Exfoliative cytology
Exogenous estrogen therapies
Experimental therapies (clinical trials)
Exploration of the abdominal cavity during surgery
Exposure to alkylating chemotherapy agents for previous malignancies
Exposure to asbestos-containing soil
Exposure to beryllium
Exposure to caustic substances
Exposure to certain chemicals
Exposure to certain chemicals (e.g., Agent Orange)
Exposure to certain chemicals (e.g., benzene, tobacco smoke, pesticides)
Exposure to certain chemicals (e.g., chlorophenols, phenoxy herbicides, vinyl chloride)
Exposure to certain chemicals (e.g., polychlorinated biphenyls, dioxins, phenoxy herbicides)
Exposure to certain chemicals (e.g., tobacco smoke, pesticides, benzene)
Exposure to certain chemicals (general for soft tissue sarcomas)
Exposure to certain chemicals (PCBs, PAHs, organic solvents)
Exposure to certain chemicals in the workplace
Exposure to certain toxic substances at work
Exposure to certain types of radiation
Exposure to certain types of radiation (e.g., radiation treatments to head or neck as a child, radiation emergency, repeated radiation exposure to chest or neck)
Exposure to certain types of radiation (head or neck radiation treatment as a child, radiation emergency)
Exposure to certain workplace chemicals
Exposure to diethylstilbestrol (DES) before birth
Exposure to Epstein-Barr virus (EBV)
Exposure to erionite
Exposure to hazardous substances
Exposure to heavy metals (e.g., mercury, lead)
Exposure to herbicides (potential risk factor, though not specifically proven for HCL)
Exposure to high doses of radiation
Exposure to high-dose ionizing radiation
Exposure to higher estrogen levels
Exposure to infection early in life
Exposure to natural and artificial ionizing radiation
Exposure to nickel
Exposure to nitrosamines
Exposure to petrochemicals (e.g., benzene)
Exposure to radiation therapy to the breast or chest
Exposure to radionuclides (Cesium-137 and Iodine-131)
Exposure to some hair dyes
Exposure to some pesticides
Exposure to soot
Exposure to SV40, HHV-6, and cytomegalovirus (CMV)
Exposure to talc
Exposure to talc mines or mills
Exposure to tar
Exposure to Thorotrast (thorium dioxide)
Exposure to ultraviolet radiation (UV)
Exposure to UV radiation from tanning devices
Exposure to vinyl chloride
Exposure to wood dusts or certain other toxic substances at work (for upper throat, nose, and sinus cancers)
Extensive disease with malignant plasma cell infiltrations in organs
Extensive necrotic focus involving skin and subcutaneous tissue
External beam radiotherapy (EBRT)
External beam therapy (proton therapy)
External irradiation
External radiation exposure (associated, but more common with adenoma)
External-beam radiation therapy (EBRT)
Extra X chromosome
Extra-abdominal desmoid tumor
Extradural ependymoma
Extranodal marginal zone B cell lymphoma
Extranodal marginal zone B-cell lymphomas (MALT type)
Extranodal NK-T-cell lymphoma
Extrapulmonary small cell carcinomas (ESCC or EPSCC)
Extraspinal ependymoma (EEP)
Extreme bone pain
Extremely long, heavy, or frequent bleeding episodes (before menopause)
Extremity leiomyosarcoma
Eye enlargement
Eye exam
Eyewall resection
Facial angiofibromas
Facial pain or numbness
Facial sensory loss
Failures of bone marrow and other organs
Faltering growth
Familial adenomatous polyposis (hereditary)
Familial cases
Familial clusters
Familial isolated pituitary adenoma (FIPA)
Family health history
Family health history assessment
Family history
Family history of AT/RT or other rhabdoid tumors
Family history of basal-cell carcinoma
Family history of chordoma
Family history of CLL or other blood and bone marrow diseases
Family history of colorectal cancer
Family history of endometrial cancer
Family history of Familial adenomatous polyposis
Family history of Hodgkin lymphoma
Family history of Li-Fraumeni syndrome
Family history of lymphoma
Family history of melanoma
Family history of meningioma
Family history of Multiple endocrine neoplasia (MEN)
Family history of paraganglioma
Family history of retinoblastoma
Family history of thyroid cancer
Family history of thyroid cancer or thyroid disease
Family history of thyroid disease
Farming and gardening (correlates with increased risk in some studies)
Fast neutron therapy
Fast neutron therapy (for advanced, inoperable, recurrent, or gross residual disease)
Fatigue (due to lack of red blood cells)
Fatigue (liver-related)
Fatigue (metastatic melanoma)
Fatty "buffalo hump" on neck (Cushing's syndrome)
Faulty genes
Favorable neuroblastoma
Favorable Wilms' tumor
Fecal occult blood testing (FOBT)
Fedratinib (Inrebic)
Feeling constipated
Feeling full
Feeling full quickly
Feeling of fullness
Feeling of fullness in the abdomen
Feeling of fullness in the affected ear
Feeling of heaviness in the scrotum
Feeling of incomplete bowel emptying
Feeling of pressure in the abdomen or pelvis
Feeling of something in the throat
Feeling that something is stuck in the throat
Feeling very thirsty
Feeling very tired
Feeling weak or sleepy
Female sex
Female sex (for FAP patients)
Female sex (minor prevalence for neuroendocrine tumors)
Female sex (modest predilection)
Fenretinide (4-hydroxy(phenyl)retinamide)
Fertility medication
Fertility-preserving surgery (unilateral salpingo-oophorectomy)
Fertilized egg implants into the uterus, but chorionic villi do not develop properly
FET gene family
Fever (intermittent)
Fever (rare, constitutional symptom)
Fibre-optic nasal endoscopy
Fibrogenic tumors (WHO 2020 classification)
Fibrolamellar
Fibrosarcoma of bone (in dogs)
Fibrosarcoma of the mouth (in dogs)
Fibrosarcoma of the skin (in cats)
Fibrosarcomatous DFSP (DFSP-FS)
Fibrous
Filgrastim (to stimulate white blood cell production, routine use not recommended after cladribine)
Fine needle aspiration (FNA) biopsy
Fine needle aspiration cytology (FNAC)
Finger-like (papillary) growth
Firm hard nodules with a scaly top (SCC)
Firm hard nodules with scaly top (SCC)
Firm nodule or mass (0.5 cm to >5 cm diameter)
Firm to the touch (nodular melanoma)
Firmness of the testicle
Fixation of lump to overlying skin
FKHR
Flank pain (due to kidney swelling from urine blockage)
Flat penile lesions (FPL)
Flexible sigmoidoscopy
Flow cytometry (detection of specific cell surface markers like CD19, CD20, CD22, CD11c, CD25, CD103, FMC7)
Flow cytometry immunophenotyping of blood cells to detect clonal phenotypes of plasma cells (e.g., CD138+, CD38+, CD19−, CD45+/- phenotype)
Flow cytometry tests (on blood, bone marrow, or other tissue)
Fluid discharge from the nipple
Fluid draining from ear
Fluid resuscitation
Fluorescence microscopy of urine cells
Fluorescent in situ hybridization (FISH) for BCR-ABL1
Fluorine-18 fluorodeoxyglucose (FDG) PET
Fluoro-deoxy-glucose positron emission tomography (F-FDG-PET)
Fluorodeoxyglucose ([18F]FDG) PET
Flushing (face, upper chest, cutaneous)
Flushing (of skin, head, upper thorax)
Flushing episodes (especially with liver metastasis)
Follicular T cell lymphoma
Follicular thyroid cancer
Food and drink going down the wrong way (aspiration)
Food sticking in the throat
Foregut GEP-NET
Formal diagnostic criteria (established in 2016)
Formation of malignant cancer cells in the primordial germ cells of the ovary
Fosbretabulin (under investigation)
Foul-smelling, fatty feces
Fractures (broken bones)
Freezing the tumor
Freezing therapy
Freezing therapy (Cryotherapy)
Frequent falls
Frequent gas pains
Frequent infections
Frequent nausea
Frequent nausea and vomiting
Frequent or urgent need to urinate
Frequent severe sunburns
Frequent sun exposure (for lip cancer)
Frequent urge to urinate
Frequent urination
Frequent vomiting
Fried foods consumption
Full blood count
Fullness
Functional imaging (18F-FDG PET, 123I-MIBG, 18F-FDOPA, 68Ga-DOTA, HED-PET)
Functional laryngectomy
Functional MRI (fMRI)
Fungation (cutaneous)
Furosemide (to decrease swelling)
FUS-DDIT3
Fusion of EWSR1 gene and FLI1 gene
Fusion of TAZ (WWTR1) and CAMTA1 genes
Fusion of the MYBL1 gene to NFIB or other partners
Fusobacterium species
Futibatinib (Lytgobi)
Gallbladder removal
Gallium-68 DOTATATE PET/CT imaging
Gallium-68 receptor PET-CT
Gallstones
Gamma Knife radiosurgery
Gastroenteropancreatic neuroendocrine tumors (GEP-NET)
Gastrointestinal leiomyosarcoma
Gastrointestinal problems (gas, bloating, constipation)
Gastroscopic exam
Gendicine (gene therapy)
Gene fusion between TMPRSS2 and the oncogene ERG
Gene therapies
Gene therapy (AdVince)
Gene therapy (e.g., CAR-T cells)
Gene therapy (experimental)
General malaise
Generalized itching (itchy skin)
Genes associated with specific subtypes
Genetic abnormalities
Genetic alteration of the TP53 gene (Li-Fraumeni syndrome)
Genetic alteration testing
Genetic alterations in RTK, PI3K/AKT/mTOR, p53, and RB pathways
Genetic analysis (for INI1/hSNF5 gene deletion/mutation)
Genetic and chromosomal testing
Genetic change in lymph node tissue (Unicentric Castleman disease)
Genetic changes (DNA mutations)
Genetic changes in bone marrow cells
Genetic changes in BRCA1 and BRCA2 genes
Genetic changes that occur during a person's lifetime
Genetic damage to the DNA of lung cells
Genetic diseases (e.g., Klinefelter syndrome, Chédiak–Higashi syndrome, ataxia–telangiectasia syndrome)
Genetic disorders (neurofibromatosis, Li-Fraumeni syndrome)
Genetic disposition (BAP1 gene mutation)
Genetic exchange between chromosomes
Genetic factors
Genetic factors (for retinoblastoma)
Genetic findings (e.g., MDM2 or CDK4 gene overexpression, sSMC or giant marker chromosome detection)
Genetic instability due to acquired abnormalities including gene mutations, single nucleotide polymorphisms, deletions, duplications, translocations, and changes in gene expression
Genetic mutations (BRAF V600E mutation is a driver mutation in nearly all cases)
Genetic mutations (BRCA1, BRCA2, CHEK2, PALB2, PTEN, ATM, RAD51L3)
Genetic mutations (DNA changes or variants)
Genetic mutations (DNA changes)
Genetic mutations (e.g., amplification of MDM2 and CDK4 genes in ALT/WDL and DDL)
Genetic mutations (e.g., FGFR2 fusion, IDH1 mutation)
Genetic mutations (e.g., in SDHx genes, RET proto-oncogene, VHL, NF1, HIF2A)
Genetic mutations (e.g., PTCH1 gene mutation)
Genetic mutations (implicit in cancer development)
Genetic mutations (inferred from familial syndromes)
Genetic mutations in AIP gene
Genetic mutations in DNA
Genetic mutations in the SMARCB1 gene
Genetic mutations in the Wnt signaling pathway
Genetic mutations that arise by chance
Genetic predisposition
Genetic sequencing of tumor cells
Genetic syndromes
Genetic syndromes (e.g., congenital melanocytic nevi syndrome)
Genetic syndromes (e.g., Familial Adenomatous Polyposis (FAP), Lynch syndrome, Gardner syndrome, Serrated Polyposis Syndrome)
Genetic syndromes (e.g., hereditary diffuse gastric cancer)
Genetic testing (e.g., BRCA, TP53)
Genetic testing (for NF2)
Genetic testing (for small cell lung cancer)
Genetic testing (RB1 gene mutation)
Genetic testing (RET proto-oncogene mutation analysis)
Genetic testing for MEN1 gene mutations
Genetic testing for RET oncogene mutations
Genetic testing for SMARCB1 mutations
Genetic testing to guide treatment
Genetic tests (BRCA, TP53)
Genetic tests (for BRAF V600E mutation)
Genetic tests (for gene and chromosome changes)
Genetic tests for gene and chromosome changes
Genetic variations in alcohol metabolism pathways
Genital lichen sclerosus
Genome-wide pattern of DNA copy-number alterations (CNAs)
Geographic location (closer to equator or higher altitudes)
Germ cell tumors (e.g., Teratoma, Sacrococcygeal teratoma)
Germ cell tumors (GCTs)
Germline duplication of brachyury
Germline mutation in the BAP1 gene
Giant cell fibroblastoma (Juvenile DFSP)
Giant cell tumor of bone (benign)
Giant-cell glioblastoma
Glandular
Glioblastoma (WHO Grade IV GBM)
Glioblastoma multiforme (GBM) with oligodendroglial component
GLMN (glomulin)
Glomangiosarcomas arising de novo (GADN)
Glomangiosarcomas arising in benign glomus tumors (GABG)
Glomus jugulare (jugulotympanic paraganglioma)
Glomus tympanicum
GNRH agonists
Goblet cell cancer
Goblet cell carcinoid
Goiter (enlarged thyroid)
Grade I tumors (WHO grading)
Grade II (low grade) tumor
Grade II tumors (WHO grading)
Grade III tumors (WHO grading)
Grade IV tumors (WHO grading)
Gross appearance (fleshy, bulky, polypoid, protruding through cervical os)
Gross appearance (tumour size, oval shape, soft consistency)
Gross examination showing pale grey, poorly defined tumour with haemorrhage and necrosis
Gross-total resection
Group 3 pathway
Group 4 pathway
Growing (nodular melanoma)
Gut microbiota and bile acid activity
Gynecomastia (historically considered, but not definitively established as a risk factor)
Gynecomastia (in males)
Gynecomastia (male)
Hairy Cell Leukemia-Variant (HCL-V)
Hard to understand speech
Having HPV (for oropharyngeal cancer)
Having many sexual partners or partners with many sexual partners
Having moles (20-30% of melanomas develop from moles)
Having moles (especially larger ones or those that change)
Having multiple sexual partners
hCG testing (for acute respiratory or neurological symptoms after pregnancy)
hCG testing (for persistent abnormal vaginal bleeding after pregnancy)
Head and neck cancer (due to field cancerization)
Head and neck radiation exposure
Head-and-neck squamous-cell carcinomas (HNSCC)
Headache (Conn syndrome)
Headache (especially morning headache or headache that resolves after vomiting)
Headache (rare)
Headache (severe, morning, or relieved after vomiting)
Headache that goes away after vomiting
Headaches (often in the morning)
Headaches (often in the morning, worsened by Valsalva maneuver, causing awakening from sleep, progressively worsening, subsiding after vomiting, due to raised intracranial pressure)
Headaches associated with increased intracranial pressure
Hearing loss (in glomus tympanicum and jugulare)
Hearing tests
Heart disease (cardiac complications, fibrosis of tricuspid and pulmonic valves, heart murmur)
Heart palpitations
Heart problems
Heat intolerance
Heat therapy (Thermotherapy)
Heavy alcohol use
Heavy chain myeloma
Heavy consumption of alcohol
Heavy drinking
Helicobacter bilis infection
Helicobacter hepaticus infection
Hematolymphoid tumours
Hematopoietic neoplasms of bone (WHO 2020 classification)
Hemoperitoneum (postmenopausal patients)
Hemoptysis (coughing up blood)
Hepatic artery chemoembolization (HACE) / Transarterial chemoembolization (TACE)
Hepatic artery chemotherapy
Hepatitis B test
Hepatitis B virus (HBV) infection
Hepatitis C test
Hepatitis C virus (HCV) infection
Hepatitis D virus (HDV) co-infection with HBV
Hepatocellular adenoma (associated with malignancy)
Hepatomegaly (enlargement of the liver)
HER-2/neu
HER2 protein test
HER2 test
HER2-positive
HER2/neu
Her2/neu
HER2/neu receptor testing
Herbicide exposure (tentative)
Hereditary conditions
Hereditary conditions (25% of cases)
Hereditary genetic defect
Hereditary genetic disorder (familial medullary thyroid cancer)
Hereditary genetic disorders (Li-Fraumeni syndrome, Muir–Torre syndromes) predisposing to various cancers
Hereditary syndromes (e.g., neurofibromatosis, Li-Fraumeni syndrome, tuberous sclerosis, Turcot syndrome)
Heritable form
Heterologous malignant mixed Müllerian tumor
HHV-8 (KSHV) infection
HHV-8-associated multicentric Castleman disease (HHV-8-MCD)
HIF2A
High alcohol consumption (three or more drinks/day)
High blood pressure
High blood pressure (Conn syndrome)
High blood pressure (hypertension)
High cholesterol (obesity-related)
High consumption of nitrosamines and nitrites
High consumption of red meat
High consumption of saturated fats
High dose chemotherapy with stem cell rescue
High doses of cyproterone acetate
High estrogen exposure (male)
High estrogen levels
High grade and more aggressive tumor
High grade serous tumors
High intake of processed meat
High intake of red meat
High intensity focused ultrasound (HIFU)
High levels of Beta-2 microglobulin
High levels of blood cholesterol
High levels of dietary nitrosamines
High levels of extremely low frequency (ELF) magnetic fields (childhood leukemia, limited evidence)
High levels of HCG (suggestive in context)
High levels of red meat consumption
High levels of serum lactate dehydrogenase
High parathyroid hormone concentration in blood (in those > 40 years)
High parathyroid hormone levels
High serum aldosterone (laboratory finding for Conn syndrome)
High socioeconomic conditions (professional/administrative workers)
High uric acid levels
High-dose chemotherapy and radiation therapy with stem cell rescue
High-dose chemotherapy followed by autologous stem cell transplantation
High-dose methotrexate with leucovorin rescue
High-dose steroids (e.g., dexamethasone) for swelling reduction
High-dose-rate interstitial brachytherapy (HDR-ISBT)
High-fat diet
High-frequency ultrasound (HFUS)
High-grade astroblastoma
High-grade astrocytoma (Diffuse zones of infiltration)
High-grade bladder cancer
High-grade serous carcinoma (HGSC)
High-grade surface OS
High-grade undifferentiated endometrial sarcoma (HGUS)
High-resolution anoscopy (using a colposcope)
High-risk HPV infection
High-risk neuroblastoma
Higher circulating testosterone levels in women
Highly active antiretroviral therapy (HAART) (for AIDS-associated KS)
Hindgut GEP-NET
HIPEC (Hyperthermic intraperitoneal chemotherapy)
Hispanic ethnicity
Histologic analysis
Histologic examination (of tumor)
Histologic examination of specimen
Histologic grading (Bloom Richardson Grade)
Histological analysis
Histological distinction between adult and juvenile forms (cytoplasm, nuclei, follicle organization)
Histological examination of biopsies
Histological examination of tissue
Histological findings
Histological grading systems (National Cancer Institute system, French Federation of Cancer Centers Sarcoma Group system)
Histology (adenocarcinoma mixed with malignant mesenchymal elements)
Histology (reticular, trabecular areas, interstitial haemorrhage, Call–Exner bodies)
Histone deacetylase inhibitors (e.g., panobinostat)
Histopathologic classification
Histopathological examination (identification of syncytiotrophoblasts and cytotrophoblasts without villi)
Histopathological typing and grading
Histopathology
Histopathology (bone marrow biopsy, immunohistochemistry, flow cytometry)
Histopathology (solid glomus tumor, glomangioma, glomangiomyoma)
Histopathology analysis of tumor tissue
Histopathology examination of tissue
Histopathology of tumors
Histopathology showing acinar, ductal or neuroendocrine differentiation
History of adenomas (colorectal polyps)
History of benign breast disease (e.g., atypical ductal hyperplasia, fibrocystic changes)
History of breast cancer or benign breast disease
History of cervical cancer
History of cigarette smoking
History of colonic polyps
History of genital warts
History of goiter (enlarged thyroid)
History of head and neck cancer
History of head or neck cancer
History of human papillomavirus (HPV) infection
History of previous abdominal surgery (for FAP patients and general recurrence)
History of radiation therapy to the chest
History of sunburns
History of symptoms
History of vaginal cancer
History of vulvar cancer
History of vulvar or cervical intraepithelial neoplasia
HIV infection (for HHV-8-associated MCD)
HIV medicines (for epidemic KS)
HIV test
HIV/AIDS
HMB-45 antibody
Hoarse voice
Hoarseness or other changes to voice
Hoarseness or other voice changes
Hodgkin lymphoma (excluded)
Homologous malignant mixed Müllerian tumor
Homologous-recombination genes
Homozygous deletion of CDKN2A/B (main feature of high-grade astrocytoma)
Homozygous deletion of ZNRF3 gene
Horizontal nystagmus
Hormonal imbalance (estrogen/progesterone) causing cell proliferation
Hormonal treatments (for uterine LMS)
Hormone replacement therapy (post-menopause)
Hormone replacement therapy for menopause (especially combined progesterone/estrogen)
Hormone therapy (androgen deprivation therapy, GnRH agonists, GnRH antagonists)
Hormone therapy (e.g., tamoxifen, anastrozole)
Hormone therapy (e.g., tamoxifen, aromatase inhibitors, GnRH-targeted drugs, CDK4/6 inhibitors, mTOR inhibitors)
Hormone therapy for menopause symptoms
Hostility
HPV (risk factor for oropharyngeal cancer)
HPV (risk factor for oropharyngeal cancer, but mentioned in general throat cancer context)
HPV 16
HPV 18
HPV 33
HPV E6 protein degrading tumor suppressor protein p53
HPV E7 protein degrading and inactivating tumor suppressor protein pRb
HPV infection (for cancers in the tonsils and base of the tongue)
HPV infections (for squamous-cell skin cancer)
HPV infections (increase risk of squamous-cell skin cancer)
HPV test
HPV vaccination (as a primary prevention measure, also reduces risk of cancerous changes)
HPV viral proteins E6 and E7 inducing cancer
HPV-negative head and neck cancer
HPV-negative oropharyngeal cancer
HPV-positive head and neck cancer
HPV-positive oropharyngeal cancer
HPV-related precursor lesions (squamous hyperplasia, low-grade penile intraepithelial neoplasia, high-grade PIN)
Human endogenous retroviruses (HERV-K) activity
Human herpesvirus 8 (HHV-8) infection (HHV-8-associated Multicentric Castleman disease)
Human herpesvirus 8 (in Kaposi sarcoma, though distinct from typical STS)
Human herpesvirus-8 (HHV-8) infection in combination with immune suppression
Human immunodeficiency virus (HIV) type 1 infection
Human papillomavirus (HPV) (for WHO type I NPC)
Human papillomavirus (HPV) infection (especially high-risk types like HPV-16)
Human papillomavirus (HPV) infection (possible association with ESCC)
Human papillomavirus (HPV) infection (possible association)
Human papillomavirus (HPV) type 16 infection
Human T-lymphotropic virus (HTLV-1)
Human T-lymphotropic virus infection (for some non-Hodgkin lymphomas)
Hungarian descent
Hybrid tumours
Hydrochlorothiazide diuretics use
Hydronephrosis with flank pain (due to blocked ureters)
Hydroxyurea (hydroxycarbamide)
Hypercalcemia (high blood calcium levels)
Hypercalcemic crisis
Hyperglycemia (high blood sugar)
Hyperhidrosis (excessive sweating)
Hypermutated tumor types
Hypertension (high blood pressure)
Hyperthermic intraperitoneal chemotherapy (HIPEC) with docetaxel and cisplatin
Hyperthermic intrathoracic perfusion chemotherapy (ITH)
Hypokalemia (low serum potassium, Conn syndrome)
Hypomethylating agents (e.g., azacitidine, decitabine)
Hypoplastic MDS
Hypotension (during carcinoid crisis)
Hysterectomy (radical hysterectomy)
Hysteroscopy (with biopsy)
Iatrogenic (transplant-related) Kaposi sarcoma
Icelandic descent
Identification of blue cells attempting to form primitive tubules (in testicle)
Identification of Reed–Sternberg cells in lymph node biopsies
Idiopathic multicentric Castleman disease (iMCD)
Ifosfamide alone
Ifosfamide with mesna
IgA myeloma
IgD myeloma
IgE myeloma
IGF-II
IgG myeloma
IGHV (immunoglobulin gene VH4-34 rearrangement is a poor prognostic factor)
IgM myeloma
IHC (vimentin positive, cytokeratin negative, S100 negative, actin variable)
Image assessment
Imaging
Imaging (CT scan, MRI scan)
Imaging (CT scan, PET scan, MRI, ultrasound)
Imaging (CT scans, MRIs, PET/CTs, ultrasound) for metastasis
Imaging (implied for assessing organ involvement and bilaterality)
Imaging (MRI of brain and spine, CT of chest and abdomen)
Imaging (MRI, CT)
Imaging (MRI, ultrasound, bone scan)
Imaging (PET scan, CT scan) for staging
Imaging (ultrasound or MRI) for surveillance (not recommended without symptoms)
Imaging studies (CT, MRI, ultrasound)
Imaging studies (ultrasound, CT, MRI)
Imaging studies of abdomen and pelvis
Imaging tests
Imaging tests (chest x-ray, CT or MRI scans)
Imaging tests (chest X-ray, CT scan, MRI)
Imaging tests (CT scan, endoscopic ultrasound, MRI, positron emission tomography, abdominal ultrasound)
Imaging tests (CT scan, MRI)
Imaging tests (CT scan, MRI, PET scan)
Imaging tests (CT scan, PET scan, abdominal ultrasound)
Imaging tests (CT scan, PET, MRI)
Imaging tests (CT, PET, MRI)
Imaging tests (CT/CAT scan, chest X-ray)
Imaging tests (e.g., CT scan, PET scan, abdominal ultrasound)
Imaging tests (e.g., CT scans for abdominal lymphadenopathy)
Imaging tests (e.g., MRI, CT, ultrasound)
Imaging tests (e.g., MRI, CT, ultrasound) for cancer spread
Imaging tests (head and neck cancer)
Imaging tests (mammogram, ultrasound, MRI)
Imaging tests (mammogram, ultrasound, MRI, tomosynthesis)
Imaging tests (MIT, CT, PET scans)
Imaging tests (MRI, CT, ultrasound)
Imaging tests (to determine location and extent of tumors)
Imaging tests (to determine spread)
Imaging tests (transvaginal ultrasound, abdominal ultrasound, CT scan, MRI)
Imaging tests (ultrasound, CAT scan, MRI)
Imaging tests (ultrasound, CT scan, MRI)
Imaging tests (Ultrasound, CT scan, MRI, MRCP)
Imaging tests (ultrasound, MRI, CT scan, PSMA scan, bone scintigraphy)
Imaging tests (x-rays, CT scan, ultrasound, MRI, MIBG scan)
Imaging tests of the liver and bile ducts
Imatinib (Gleevec)
Imatinib mesylate (tyrosine kinase inhibitor, for unresectable, recurrent, or metastatic DFSP)
iMCD with idiopathic plasmacytic lymphadenopathy (iMCD-IPL)
iMCD with TAFRO Syndrome (iMCD-TAFRO)
iMCD, not otherwise specified (iMCD-NOS)
Imiquimod (topical cream)
Imiquimod cream (immunotherapy)
Immature liver precursor cells
Immature or embryonal cells
Immune checkpoint inhibitors (e.g., pembrolizumab)
Immune checkpoint inhibitors (e.g., pembrolizumab, atezolizumab, nivolumab, avelumab)
Immunocompromised state (for HHV-8-associated MCD)
Immunodeficiency (due to HIV/AIDS, organ transplantation, rheumatoid arthritis)
Immunohistochemical analysis
Immunohistochemical staining
Immunohistochemical staining (e.g., for CD34, S-100 protein, hormone receptors)
Immunohistochemical staining for muscle-specific proteins (myogenin, muscle-specific actin, desmin, D-myosin, myoD1)
Immunohistochemistry (Chromogranin-A, Synaptophysin, GATA3, SOX10, S100, SDHB, Inhibin A, CAIX, TH, DBH, ChAT, Ki67)
Immunohistochemistry (detecting brachyury and cytokeratin expression)
Immunohistochemistry (e.g., CD99 positive, MIC2 positive, CD45 negative)
Immunohistochemistry (for genetic mutations)
Immunohistochemistry (IHC) for neuroendocrine markers (synaptophysin, chromogranin A) and other markers (PAX5, cytokeratin 20)
Immunohistochemistry (using BerEP4)
Immunohistochemistry testing (e.g., positive for keratin, p53, PAX8; negative for thyroid transcription factor-1, thyroglobulin, calcitonin)
Immunohistological characterization of tumors
Immunomodulator agents (e.g., thalidomide, lenalidomide, pomalidomide)
Immunomodulatory agents (e.g., lenalidomide, pomalidomide, thalidomide)
Immunoreactivity for GFAP
Immunoreactivity for neuroendocrine differentiation markers
Immunoreactivity for vimentin
Immunosuppressant medications
Immunosuppression (e.g., following kidney transplantation)
Immunosuppression (e.g., HIV infection, organ transplant recipients, certain malignancies)
Immunosuppressive medications (e.g., Cyclosporin A, azathioprine)
Immunotherapeutics (Bevacizumab, Nivolumab)
Immunotherapy (anti-GD2 monoclonal antibody therapy - dinutuximab)
Immunotherapy (atezolizumab, bevacizumab, tremelimumab)
Immunotherapy (being studied)
Immunotherapy (cytokines like IFN-a and IL-2, immune checkpoint inhibitors like ipilimumab, nivolumab, pembrolizumab, anti-PD-1 antibodies, anti-CTLA-4 antibodies)
Immunotherapy (Durvalumab (Imfinzi))
Immunotherapy (e.g., atezolizumab for alveolar soft part sarcoma)
Immunotherapy (e.g., atezolizumab, pembrolizumab)
Immunotherapy (e.g., atezolizumab, pembrolizumab, spartalizumab)
Immunotherapy (e.g., immune checkpoint inhibitors, Pembrolizumab, Dostarlimab)
Immunotherapy (e.g., nivolumab)
Immunotherapy (e.g., nivolumab, pembrolizumab)
Immunotherapy (e.g., toripalimab-tpzi with cisplatin and gemcitabine)
Immunotherapy (immune checkpoint inhibitors)
Immunotherapy (immune checkpoint inhibitors: pembrolizumab (Keytruda), cemiplimab-rwlc (Libtayo), Tisotumab vedotin (Tivdak))
Immunotherapy (interferon, interleukin-2)
Immunotherapy (nivolumab, ipilimumab, interferon alpha)
Immunotherapy (nivolumab, pembrolizumab)
Immunotherapy (PD-1/PDL1 inhibitors like avelumab, pembrolizumab, nivolumab, ipilimumab)
Immunotherapy (Sipuleucel-T)
Immunotherapy (under research)
Impaired bile flow
Impaired breathing (due to lung metastasis)
Impaired breathing (due to pleural effusion from lung metastasis)
Implants (hard metals or silicone)
Impotence (in men, Feminization)
Improved airflow
Inability to pass urine
Inability to stand, crawl, or walk
Inactivation of p53 tumor suppressor
Inactivation of RB tumor suppressor
Inactivation of RB1 tumor suppressor gene in myxoid pleomorphic liposarcoma
Inattentiveness
Incidental discovery (incidentalomas)
Incidental finding during cholecystectomy for gallstones
Increase in bone marrow fibrosis
Increased blood calcium levels (hypercalcemia)
Increased expression of HER-2/neu
Increased granulocytes (neutrophils, eosinophils, basophils)
Increased head size (in infants)
Increased head size in infants
Increased number of ovulatory cycles
Increased quantitative chorionic gonadotropin levels
Increased red bloods (polycythemia)
Increased risk of aspiration pneumonia
Increased risk of thrombosis
Increased sedimentation rate
Increased serum glucose (laboratory finding for Cushing's syndrome)
Increased susceptibility to infection (e.g., pneumonia)
Increased susceptibility to infections
Increased urine cortisol (laboratory finding for Cushing's syndrome)
Increased uterine size
Increasing age
Increasing age (> 60 years)
Indigestion (dyspepsia)
Indirect laryngoscopy
Individuals with hyperparathyroidism
Individuals with pheochromocytoma
Indoor air pollution from burning wood, charcoal, or crop residue
Induration of mucosa
Infantile cholestasis
Infantile choriocarcinoma of liver
Infection (for primary tumors)
Infection with Helicobacter bilis bacteria
Infection with Helicobacter hepaticus bacteria
Infection with HPV
Infection with human herpesvirus-8 (HHV-8)
Infection with human immunodeficiency virus (HIV)
Infection with human T-lymphotropic virus type 1 (HTLV-1)
Infection with liver flukes (Opisthorchis viverrini, Clonorchis sinensis)
Infection with oncogenic CMV (potentially necessary for development)
Infection with simian virus 40 (SV40)
Infections (due to low white blood cell count)
Infections by some forms of HPV
Infestation with the parasite Spirocerca lupi (in dogs)
Infigratinib (Truseltiq)
Infiltrative basal-cell carcinoma
Inflammation (for primary tumors)
Inflammation of the bile duct
Inflammation of the mouth or throat (mucositis)
Inflammatory bowel disease (e.g., chronic ulcerative colitis, Crohn disease)
Inflammatory bowel disease (ulcerative colitis and Crohn's disease)
Inflammatory breast cancer
Inflammatory markers test
Inflammatory symptoms
Infrared photocoagulation (for localized disease/precursor lesions)
Ingestion of caustic substances
Inguinal orchiectomy (surgical removal of the testicle for tissue examination)
Inhalation of other fibrous silicates
Inhaling damaging chemicals
Inherited BRCA1 or BRCA2 gene mutations
Inherited BRCA1/BRCA2 mutations impairing DNA repair
Inherited diseases (e.g., neurofibromatosis type I, inherited retinoblastoma)
Inherited disorders such as Li-Fraumeni syndrome
Inherited familial syndromes (MEN1, MEN2, VHL disease, neurofibromatosis type 1, tuberous sclerosis, Carney complex)
Inherited gene duplication
Inherited genetic changes
Inherited genetic changes (hereditary breast cancer)
Inherited genetic changes (hereditary ovarian cancer)
Inherited genetic component
Inherited genetic mutations
Inherited genetic predisposition (e.g., BRCA1, BRCA2, PALB2, TP53, PTEN, PALB1 mutations)
Inherited germline mutations (e.g., INI1, SMARCB1)
Inherited inactivation mutation in TP53 gene
Inherited mutations
Inherited risk of breast cancer
Inherited risk of breast cancer (e.g., BRCA1/BRCA2 gene changes)
Inhibin A
INI1 (hSNF5/INI1)
INI1/hSNF5 gene deletions or mutations
Injections of chemotherapy into the lesion
Inspection of the perineum
Integration of high-risk HPV DNA into host genome
Interaction of environmental factors and genetic susceptibility
Interferon treatment
Interferon-alpha
Interferon-alpha (immune system hormone)
Interferon-beta
Intermediate-risk neuroblastoma
Internal radiotherapy (brachytherapy)
International consensus diagnostic criteria for iMCD (established in 2017)
Interphase fluorescence in situ hybridization (FISH) testing
Interruption to organ function
Interstitial fibrosis
Intestinal transplant
Intra-abdominal desmoid tumor
Intra-arterial cisplatin
Intraductal papillary mucinous neoplasm (IPMN)
Intrahepatic stones (hepatolithiasis)
Intranasal drug delivery (experimental)
Intraocular cancer
Intraosseous (central) salivary gland tumours
Intrapleural thorium dioxide (thorotrast)
Intrathoracic desmoid tumor
Intravenous chemotherapy
Intravesical chemotherapy (e.g., mitomycin C, epirubicin, gemcitabine, docetaxel, valrubicin)
Invasive mole
Inversions in the long arm of chromosome 12
Inverted ductal papilloma
Iodine 131-MIBG therapy
Ionizing radiation (e.g., X-rays)
Ionizing radiation (including radiation treatment for other cancers)
Ionizing radiation exposure (including CT scan radiation)
IOTA models (LR2, SRrisk, ADNEX)
Iridectomy (removal of part of the iris)
Iridocyclectomy (removal of iris and ciliary body muscle)
Iron chelation therapy (e.g., deferoxamine, deferasirox, deferiprone)
Iron overload state
Irradiation of pituitary adenoma (single case report)
Irradiation of the chest or abdomen
Isochromosome 12p
Isolated limb infusion (ILI)
Isosexual precocious puberty (in young children)
Itchiness
Itchiness of a mole
Itching (pruritus)
Itching from the anus
Itching of breast
Itching, burn, or bleeding on the vulva that does not go away
Itchy skin (liver metastases)
IVA regimen (ifosfamide, vincristine, actinomycin D)
Ivodesinib (Tibsovo)
JAK2 V617F mutation
Jaundice (due to liver metastasis)
Jaundice (liver-related)
Jaundice (yellowish skin, yellowing of eyes and skin)
Joint pain
Kallikrein-2 blood test
Karyotypic abnormalities
Keratocystoma
Kidney abnormalities
Kidney disease requiring dialysis
Kidney function tests
Kidney issues
Kidney stones (under investigation)
Kinase fusions (BRAF, RAF1, ALK, RET, ROS1, NTRK1, NTRK3, MET)
KIT (CD117)
KMT2A (MLL)
KRAS mutations
Krukenberg tumors (metastasis from gastric cancer)
Lab tests
Lab tests (blood and sputum)
Laboratory abnormalities (e.g., elevated C-reactive protein)
Laboratory evaluations for hormone hypersecretion and hypopituitarism
Laboratory investigations
Lack of physical activity
Lack of physical exercise
Lactate dehydrogenase (LDH) test
Lanreotide (somatostatin analogue)
Laparoscopic retroperitoneal adrenalectomy
Laparoscopic transperitoneal adrenalectomy
Large brownish spot with darker speckles
Large cell neuroendocrine carcinoma of the lung (LCNEC)
Large doses of Sr-90
Large mass (SCC, if untreated)
Large mass (untreated SCC)
Large mass in the neck
Large tumor size
Large-cell carcinoma
Laryngeal reflux disease
Laser excision
Laser photocoagulation
Late menopause
Lateral rectus palsy
LDH levels (may be elevated in metastatic melanoma)
Leakage of urine or faeces from the vagina (rare)
Leg weakness or paralysis
Lenvatinib in combination with everolimus
Leptin overexpression
Leser-Trelat sign
Lesions in the lungs
Lesions in the mouth (hard palate, gums)
Lesions in the stomach or intestines
Lesions on legs and feet (ankles, soles)
Leukapheresis therapy
Leukoerythroblastic smear (tear-drop RBCs, nucleated RBCs, immature granulocytes)
Li-Fraumeni syndrome (germline TP53 mutation)
Li-Fraumeni syndrome (hereditary)
LI-RADS classification system for liver lesions
LIBC
Lichen sclerosus
Lichen sclerosus (in HPV-negative cancers)
Life-threatening problems
Light chain myeloma
Light colored stool
Light microscopy (basaloid tumor nests with neuroendocrine features)
Light-colored skin, hair, and eyes
Light-colored stools
Lighted tube-like instruments that look inside the nose
Lighter skin color
Lighter skin, hair, and eye color
Limb amputation (for unresectable limb tumors)
Limb-saving surgery
Limited stage SCLC
Limping
Lip or mouth sore that won't heal
Liposomal anthracyclines (e.g., liposomal doxorubicin, daunorubicin)
Liquid biopsy (experimental, from blood, CSF, urine)
Listlessness
Liver and gallbladder NETs
Liver biopsy (historically required, now often not needed if imaging is conclusive)
Liver enlargement
Liver enzymes
Liver Imaging Reporting and Data System (LI-RADS)
Liver transplantation (in cases of liver metastasis)
Liver-directed therapies (radiofrequency ablation, radioembolization for liver metastases)
Living close to the equator
Living in crowded and less hygienic conditions (for EBV transmission)
Living near asbestos mines or factories
Living near naturally occurring asbestos deposits
Living with asbestos workers
Local recurrence (following surgery in dogs and cats)
Local skin flap
Localized immunodeficiency
Localized neurological problems
Localized swelling
Locally infiltrative glomus tumors (LIGT)
Loco-regional therapy
Locoregional therapies
Locoregional therapies (Transarterial chemoembolization (TACE), Transarterial radioembolization (TARE), Ablation therapies)
Long time to chew and swallow food
Long-lasting infection with high-risk human papillomavirus (HPV)
Long-standing foreign bodies
Long-standing goiter
Long-term arsenic exposure
Long-term diabetes
Long-term indwelling catheters
Long-term use of oral contraceptives
Long-term use of pioglitazone (for type 2 diabetes)
Loop electrical excision procedure (LEEP) (for severe precancerous lesions)
Loose teeth or dentures that no longer fit well
Loss of appetite (anorexia)
Loss of appetite (metastatic melanoma)
Loss of balance
Loss of bladder control
Loss of function
Loss of function (if impinging on nerves)
Loss of GATA-3 (leading to dedifferentiation)
Loss of hearing on one side
Loss of identity
Loss of p53 and pRb leading to increased blood vessel growth (VEGF over-expression), loss of tumor cell suppression, and cell cycle regulation disruptions
Loss of PTEN function leading to PI3k/Akt/mTOR pathway up-regulation
Loss of sensation (if impinging on nerves)
Loss of tumor suppressor genes on chromosome 3
Loss-of-function mutations in tumor suppressor genes (NF1, TP53, CDKN2A)
Low back pain (lumbago)
Low blood pressure (hypotension)
Low blood sugar
Low body mass index (<18.5 kg/m2)
Low grade malignant tumors
Low grade serous tumors
Low immune function
Low intake of dairy products
Low intake of water
Low levels of skin pigment melanin
Low plasma renin activity (laboratory finding for Conn syndrome)
Low serum potassium (laboratory finding for Conn syndrome)
Low socioeconomic status
Low vitamin D levels (disproven)
Low-dose morphine
Low-dose sedatives
Low-grade astroblastoma
Low-grade bladder cancer
Low-grade central OS
Low-grade cribriform cystadenocarcinoma
Low-grade serous carcinoma
Low-grade tumor
Low-risk neuroblastoma
Lozenges
Lu-177 PSMA
Lumbar puncture (cerebrospinal fluid testing)
Lumbar puncture (elevated CSF protein levels)
Lumbar puncture (to check for M1 disease)
Lump
Lump (nodule) in the neck
Lump at end of penis
Lump in ear, cheek, jaw, lip, or inside the mouth
Lump in the abdomen
Lump in the abdomen, neck, or chest
Lump in the back of the throat or mouth
Lump in the lip, mouth, or gums
Lump in the neck
Lump in the neck (head and neck cancer, not glomus tumor)
Lump in the pelvic area
Lump in the vulva
Lump near the anus
Lump or mass on the back of the neck (often not tender or painful)
Lump or pain on the right side of the abdomen
Lump or swelling in soft tissue
Lump or thickness in the perineum or penis
Lumps in the abdomen
Lumps under the skin
Lutetium (177Lu) DOTA-octreotate (for metastatic disease)
Lymphadenectomy (removal of pelvic and para-aortic lymph nodes)
Lymphadenoma
Lymphedema (swelling due to lymphatic system obstruction)
Lymphedema (swelling in genitals or lower limbs)
Lymphedema associated angiosarcoma (Stewart-Treves syndrome)
Lymphocyte depleted
Lymphocyte-rich
Lymphoepithelioma
Lymphoepithelioma like
Lymphohistiocytic
Lymphomas (e.g., extranodal marginal zone B-cell lymphomas, diffuse large B-cell lymphomas)
Lymphomatous meningitis (LM)
Lynch syndrome
Lynch syndrome (hereditary)
Macroadenomas
Magnetic Resonance Angiography (MRA) (with or without gadolinium contrast)
Magnetic resonance imaging (MRI) (for assessing depth of invasion)
Magnetic Resonance Imaging (MRI) (with contrast enhancement, T1, T2, FLAIR imaging)
Magnetic resonance imaging (MRI) of the brain (to assess for distant metastases)
Magnetic resonance imaging (MRI) scan
Magnetic resonance imaging (MRI) with T2-weighted imaging showing a tail sign
Magnetic Resonance Spectroscopy (MRS) (proton spectroscopy)
Maintenance regimen of lenalidomide, bortezomib, and dexamethasone
Male gender (in myxoid liposarcoma)
Male sex
Male sex (4:1 male to female ratio for classic HCL)
Male sex (especially for EAC)
Male sex (for Ewing's sarcoma)
Male sex (for subependymoma subtype)
Male sex (in the US)
Male sex (up to 45 years old)
Malfunction of Schwann cells that form the insulating myelin sheath on the vestibulocochlear nerve
Malignancy may be focally present in mucinous neoplasms of the ovary
Malignant mixed müllerian tumor (carcinosarcoma)
Malignant mucinous tumors
Malignant peripheral nerve-sheath tumors
Malignant plasma cell-secreted circulating monoclonal myeloma protein (IgG, IgA, light chain, or none)
Malignant Rhabdoid Tumor of the Brain
Malignant Rhabdoid Tumor of the Kidney
Malignant Rhabdoid Tumor of the Soft Tissues
Malignant triton tumors (MPNST with rhabdomyoblastomatous component)
Malnutrition and weight loss (due to refusal to eat)
Many moles
Many sexual partners
Marfanoid habitus
Marijuana smoking
Mass in the abdomen
Mastectomy (total mastectomy)
Maternal age over 35 years
Maternal age over 45 years
Maternal age under 16 years
Maternal age under 20 years
Maternal ovum with no functional DNA (complete hydatidiform mole)
Maternal use of hair dye
Maximal surgical removal of the tumor
Maximum surgical resection
MCV-negative MCC
MCV-positive MCC
MDM2 SNP309
MDS unclassifiable
MDS with bi-allelic TP53 inactivation
MDS with fibrosis
MDS with increased blood counts
MDS with single lineage dysplasia
Measles virus
Measurement of corresponding hormones in blood or urine
Measurement of free PSA
Measurement of serum beta hCG
Meat cooked at very high temperatures
Medical history
Medical history (including symptoms and family health history)
Medical history and family health history review
Medical history and symptom assessment
Medical history assessment
Medical imaging (e.g., CT scan, PET scan, MRI)
Medical imaging (for cancer staging)
Medical imaging (skeletal survey, MRI, CT scan)
Medical imaging (to determine spread)
Medical imaging (ultrasound, CT scan, MRI) to check for tumor spread or alternative diseases
Medical imaging to characterize kidney masses
Medical therapies (clinical trials for drugs like everolimus, lapatinib, mifepristone)
Medical treatments (e.g., radiation therapy, chemotherapy)
Medical ultrasonography
Medical ultrasound
Medication (cabergoline, bromocriptine, somatostatin receptor ligands like octreotide or lanreotide, pegvisomant, ketoconazole, metyrapone, osilodrostat, etomidate, mitotane, pasireotide, mifepristone)
Medications to improve digestion (pancreatin)
Mediterranean heritage
Medullary thyroid cancer
Medullary thyroid cancer associated with Multiple Endocrine Neoplasia type 2A (MEN2A)
Medullary thyroid cancer associated with Multiple Endocrine Neoplasia type 2B (MEN2B)
Medulloepithelioma (Diktyoma)
MEK inhibitor (e.g., trametinib)
MEK inhibitors (e.g., trametinib, cobimetinib)
Melanoma in situ
Melanoma with features of a Spitz nevus
Melanoma with small nevus-like cells
Memory loss
MEN type 2A and 2B
Men2B
MEN4
MenA
menin
Meningothelial
Menometrorrhagia (reproductive age patients)
Menopause at a later age
Mental changes
Mental confusion
Merkel-cell carcinoma
Mesenchymal cells failing to differentiate into myocytes of skeletal muscle
Mesenchymal stromal cells (uncertain therapeutic effect)
Mesenteric desmoid tumor
Mesenteric fibrosis
Mesoblastic nephroma
Meta-iodobenzylguanidine (mIBG) scan
Metabolic assessment
Metabolic syndrome with NAFLD
Metaplastic sarcomatous transformation of the epithelial component (Conversion/divergence hypothesis)
Metastases from breast cancer
Metastases from lung cancer
Metastases to the pituitary gland
Metastasis associated in colon cancer 1 (MACC1)
Metastasis from breast cancer
Metastasis from Breast cancer
Metastasis from Colon cancer
Metastasis from colon cancer
Metastasis from Kidney cancer
Metastasis from Lung cancer
Metastasis from Melanoma skin cancer
Metastasis from other cancers (e.g., Lung cancer, Breast cancer, Thyroid cancer, Kidney cancer, Prostate cancer)
Metastasis from other primary cancers (e.g., breast cancer, lung cancer, prostate cancer, kidney cancer, thyroid cancer, skin cancer, colon cancer, blood cancer, bone marrow cancer)
Metastasis from tumors of the female genital tract
Metastasis of neuroendocrine tumors to the liver (allowing substances to bypass first-pass metabolism)
Metastasis to lungs, bone, and lymph nodes
Metastasizing pleomorphic adenoma
Metastatic bladder cancer
Metastatic Eye Cancer
Metastatic pheochromocytoma
Metastatic symptoms depending on affected organ
Methotrexate (chemotherapy drug)
Microadenomas
Micronodular basal-cell cancer
Microscopic analysis (histology) of enlarged lymph node tissue
Microscopic evaluation of carcinomatous cells below basement membrane of lactiferous ducts invading stroma
Microscopic examination (pathology)
Microscopic examination of biopsy (amyloid stroma, hyperplasia of parafollicular cells)
Microscopic examination of cells
Microscopic examination of specimens
Microscopic examination of thyroid tissue
Microscopic examination of tissue
Microscopic features including indistinct cell borders, mitoses, variable architecture (tubulopapillary, glandular, solid, embryoid bodies), nuclear overlap, and necrosis
Microscopy (small, round, blue cells, Homer Wright pseudorosettes)
Microvascular free flap
Middle-aged large and giant breed dogs
Midgut carcinoid
Midgut GEP-NET
Mifamurtide (after surgery, with chemotherapy)
Migratory venous thrombophlebitis
Milky nipple discharge unrelated to normal breast-feeding (galactorrhea)
Minimal symptomatology despite large tumor size (seminomas)
Minor firm area of skin (1-5 cm in diameter)
Mismatch repair (MMR) deficient colorectal cancer
Mismatch repair (MMR) deficient tumours
Misuse of pain medicines for a long time
Mitochondrial dysfunction
Mitomycin C (MMC)
Mixed cellularity
Mixed Epithelial / Mesenchymal Type
Mixed tumors (neuroendocrine and epithelial carcinoma features)
MLH2
MLH6
MLL2
Moderate to severe hypercalcemia
Mogamulizumab-kpkc (Poteligeo)
Mohs micrographic surgery (MMS)
Mole evolving over time
Molecular characterization (e.g., IDH1/IDH2 mutation status, EGFR amplification, TERT promoter mutation, ATRX expression)
Molecular findings
Molecular pathology (identifying chromosomal translocations, e.g., t(11;22))
Momelotinib (Ojjaara)
Monoclonal antibodies (e.g., daratumumab, isatuximab, elotuzumab, belantamab mafodotin)
Monoclonal antibody therapy (e.g., cetuximab)
Mood changes (e.g., depression, anxiety)
Moon face
Morning headache
Morpheaform basal-cell cancer
Morphology and special stains (PAS, Perls' Prussian blue iron stain)
Motor system imbalance
Motor system weakness
Mouth symptoms (pain, numbness, swelling, jaw expansion, tooth mobility, radiolucency)
Moxetumomab pasudotox (anti-CD22 immunotoxin, for relapsed disease)
MPL W515L mutation
MR cholangio-pancreatography (MRCP)
MR spectroscopy (for tumor metabolite concentration, e.g., increased choline peak)
MRI
MRI (with gadolinium)
MRI imaging
MRI of upper urinary tract
MRI scan
MRI scan (often appearing as ring-enhancing lesions)
MRI scan (soft tissue, medullary cavity)
MRI scans
MRI-images analyzed following nerve tracts up to the brainstem
mTOR inhibitors (everolimus)
mTOR mutations
Mucohyaline
Mucosal ablation (e.g., radiofrequency ablation, photodynamic therapy, Nd-YAG laser, argon plasma coagulation)
Mucosal neuromas
Multi-agent chemotherapy
Multifocal AT/RT
Multilocular clear cell RCC
Multimodal therapy (combination of surgery, chemotherapy, radiation)
Multimodality therapy (combination of surgery, radiation, and chemotherapy)
Multiple atypical nevi or dysplastic nevi
Multiple endocrine neoplasia (inherited condition)
Multiple endocrine neoplasia (MEN) (hereditary)
Multiple endocrine neoplasia type 2 (MEN2A and MEN2B)
Multiple pregnancies (especially seven or more full-term pregnancies)
Mumps orchitis
Muramyl tripeptide
Muscle inflammation
Muscle loss
Muscle loss (shoulder)
Muscle wasting (Cushing's syndrome)
Muscle weakness (Conn syndrome)
Muscle-invasive bladder cancer (MIBC)
Mutation in the RET proto-oncogene (sporadic and hereditary)
Mutation in the tumor suppressor gene, NF2, located on chromosome 22, resulting in abnormal production of the cell protein Merlin
Mutation of T cells
Mutation of the p53 tumor suppressor gene
Mutations affecting cellular machinery
Mutations affecting genes involved in cell growth, replication, cell death, and DNA damage repair
Mutations and deletions of tumor suppressor genes (e.g., P53)
Mutations in ACVR2A
Mutations in ACVR2A, TGFBR2, MSH3, MSH6, SLC9A9, BRAF genes (hypermutated tumors)
Mutations in ATM
Mutations in AXIN1, AXIN2, TCF7L2, NKD1 genes
Mutations in BAX
Mutations in BAX gene
Mutations in BRAF genes (V600E, V600K)
Mutations in CTDNEP1
Mutations in CTNNB1 (β-catenin) gene
Mutations in DNA repair genes (e.g., TP53, BRCA1, BRCA2)
Mutations in FAM123B
Mutations in FAM123B, SOX9, ATM, ARID1A genes (non-hypermutated tumors)
Mutations in genetic material (DNA)
Mutations in KRAS, RAF, PI3K genes
Mutations in mismatch repair genes (e.g., MLH1, MLH2, MSH2, MSH6, PMS2)
Mutations in MLL2
Mutations in NKD1
Mutations in PTEN tumor suppressor gene
Mutations in RAS genes (NRAS, HRAS, KRAS)
Mutations in RPL22 gene
Mutations in SLC9A9
Mutations in SMAD
Mutations in TBR1
Mutations in TGFBR2
Mutations in the APC gene
Mutations in the APC gene (Ashkenazi Jews)
Mutations in the genes for MenA and Men2B
Mutations in the TP53 gene
Mutations in the Wnt signaling pathway
Mutations in tumor suppressor genes (e.g., p53, PTEN, SPOP)
Mutations of MAX
Mutations of NF1
Mutations of SDHAF2
Mutations of SLC25A11
Mutations of the genes for the succinate dehydrogenase (SDHD, SDHA, SDHC, SDHB)
Mutations of TMEM127
Mutations of VHL
Mutations that disable SPOP
Mutations that hyperactivate FOXA1
MYB activation by copy number gain
MYB activation by juxtaposition of enhancer elements near the MYB gene
MYB gene fusion with the NFIB gene due to t(6;9) translocation
MYCN oncogene amplification
Mycobacterium leprae infection
Myeloablative therapy
Myelofibrosis (iMCD-TAFRO)
Myeloid neoplasms with germ line predisposition and organ dysfunction
Myeloma-defining events (MDEs)
Myxoid DFSP
N'-nitrosonornicotine (in smokeless tobacco)
N-terminally truncated variant of Hsp70
Nadofaragene firadenovec (Adstiladrin)
Nail clubbing
Naloxone lotion (for pruritus)
Nanoparticle-based therapeutics (experimental)
Nanoparticulate chemotherapy
Nasal cavity paraganglioma
Nasal obstruction or bleeding
Nasal regurgitation due to paresis of the soft palate
Nasal twang
Nasogastric tube feeding
Nath Score (risk assessment model)
Native American ethnicity
Nausea (liver or brain metastases)
Nausea (metastatic melanoma)
Nausea or vomiting (especially over 50)
Nausea/vomiting
NBS1
Needle biopsy (fine-needle aspiration or core needle biopsy)
Neoadjuvant chemotherapy
Neoadjuvant chemotherapy (before surgery)
Neoadjuvant chemotherapy (for advanced cancer)
Neoadjuvant chemotherapy and/or radiotherapy (for invasive/large tumors)
Neoplastic processes (for primary tumors)
Nephrogenic rests (fragments of tissue that develop before birth and become cancerous after birth)
Nerve damage (peripheral neuropathy)
Nestin
Nestin testing
Neuroendocrine tumor of the anterior pituitary
Neuroendocrine tumors (formerly carcinoid tumors)
Neuroendocrine tumors arising in the bronchi (allowing products to reach systemic circulation before liver metabolism)
Neurofibromatosis (inherited syndrome)
Neurofibromin 1
Neurologic abnormalities
Neurologic exam
Neurological care
Neurological deficits
Neurological deficits (e.g., visual loss, motor weakness, cognitive decline)
Neurological exam
Neurological signs (due to nerve pressure)
Neurological symptoms
Neurological symptoms (after pregnancy)
Neurological symptoms (if in the brain)
Neurological symptoms (migraines, seizures, coma)
Neurological symptoms (weakness, confusion, headache, visual changes, retinopathy, radicular pain, loss of bowel or bladder control, carpal tunnel syndrome, peripheral neuropathy)
Neuron-specific enolase (NSE)
Neuron-specific enolase (NSE) testing
Neuropathologist examination (for atypical cells, new blood vessel growth, mitotic figures)
Neuropsychological deficits (e.g., anxiety)
Neuroradiologic features analysis
Neurosurgery (debulking)
Neurosurgical care
Neutropenia (low neutrophil count)
Never been pregnant
Never having been pregnant
Never having been pregnant (nulliparity)
New lump on the skin (nodular melanoma)
New lump or thickening in breast or armpit
New lump or thickening in or near the breast or armpit
New mole
Newly inverted nipple
Nexavar
NF-kB
NF-κB
NF1 mutant subtype
NF2 (neurofibromatosis 2 gene)
Niacin deficiency (pellagra)
Niacin deficiency (Pellagra)
Nimustine hydrochoride (ACNU)
Nipple discharge (sudden, bloody, or from one breast)
Nipple retraction
Nipple turned inward
Nivolumab (uncertain effect)
NJDS gene
NJDS gene mutation (correlated)
Nodular basal-cell carcinoma
Nodular lymphocyte-predominant Hodgkin lymphoma
Nogapendekin alfa inbakicept (Anktiva)
Non-functioning tumors
Non-healing ulcers (in advanced disease)
Non-hypermutated colorectal cancer
Non-hypermutated tumor types
Non-keratinizing squamous cell carcinoma (lymphoepithelioma)
Non-muscle-invasive bladder cancer (NMIBC)
Non-ossifying fibroma (benign)
Non-reducing varicocele
Non-specific dermatitis
Non-specific symptoms
Non-syndromic Wilms' tumor
Nonheritable form
Nonmelanoma skin cancer (NMSC)
Nonsebaceous lymphadenoma
Northern European ancestry
Nose and sinus cancer
Notochordal tumors (WHO 2020 classification)
Nottingham system (grading)
Nuclear medicine gamma camera imaging (using radioactive somatostatin analogues like indium-111 pentetreotide)
Nuclear medicine therapy (radiolabeled peptides or hormones)
Nucleoside drugs (e.g., fludarabine, pentostatin, cladribine)
Null cell adenomas
Nulliparity
Nulliparity (never been pregnant)
Numbness in face
Numbness in limbs
Numbness in the lip and chin
Numbness in the mouth or lips
Numbness of the face
Numbness or paralysis of the face
Obesity (especially abdominal obesity)
Observation (for early stage or after resection)
Observation (wait-and-watch/wait-and-scan)
Observation (watchful waiting)
Observation with close imaging follow-up
Occupational exposure to aromatic amines (e.g., benzidine, beta-naphthylamine, ortho-toluidine)
Occupational exposure to aromatic hydrocarbon solvents (e.g., benzene, toluene, xylene)
Occupational exposure to arsenic
Occupational exposure to asbestos
Occupational exposure to asbestos (mining, production, working with asbestos products)
Occupational exposure to beryllium
Occupational exposure to certain chemicals in metalworking, petroleum, plastics, and textile industries
Occupational exposure to chromium
Occupational exposure to nickel
Occupational exposure to paint fumes
Occupational exposure to soot
Occupational exposure to UV radiation (e.g., working in airplanes)
Occupational exposure to wood dust
Occupational exposure to wood dusts or certain toxic substances
Occupations with long-term exposure to high temperatures, petrol emissions, or exhaust emissions
Octreotide (somatostatin analogue)
Older age
Older age (4th to 5th decades for carcinoids)
Older age (55-65 years old)
Older age (>50 years old)
Older age (average 66 years)
Older age (median age at diagnosis is 55-60 for classic HCL, over 70 for HCL-V)
Older age (most commonly 40-70, or over 60)
Older age (over 50)
Older age (over 60 years old)
Older age (over 60 years)
Older age (over 60, typical onset 70 years)
Older age (post-menopause)
Older age (typically after 45, average early 60s)
Oncept IL-2 (for feline vaccine-associated fibrosarcomas)
Oncogenes
Oncolytic virotherapy (experimental)
Oncolytic virus therapy (JX-594)
One-sided weakness
Oophorectomy (removal of ovaries)
Ophthalmoscopy (examination by ophthalmologist/optometrist)
Opioid painkillers
Oral contraceptive pill use (longer than five years)
Oral human papillomavirus infection (HPV)
Oral prophylaxis and hygiene
Oral tyrosine kinase inhibitors (e.g., imatinib, sorafenib, pazopanib, sunitinib)
Oral/maxillofacial surgery
Orbital swelling
Organ of Zuckerkandl paraganglioma
Organomegaly (iMCD-TAFRO)
Originating from the fimbriated end of the fallopian tube has emerged as an origin for many high-grade serous carcinomas.
Orthopnea (shortness of breath when lying flat)
Osteoarthropathy (rarely)
Osteoblastoma (benign)
Osteochondroma (benign)
Osteoclast inhibitors (alendronate, pamidronate) (in dogs)
Osteoclastic giant cell-rich tumors (WHO 2020 classification)
Osteoclastic variant
Osteogenic tumors (WHO 2020 classification)
Osteoid osteoma (benign)
Osteoma (benign)
Osteoradionecrosis of the jaw
Other blood tests
Other mesenchymal tumors of bone (WHO 2020 classification)
Other thyroid diseases
Outward growing (exophytic) growth
Ovary NETs
Overexpression of mutant p53
Overexpression of oncogenes (e.g., KRAS, RAF, PI3K)
Overweight or obesity
Ozone depletion (contributes to increased UV exposure)
p16INK4A immunostaining (for HPV-related penile cancer)
p27
P53 mutation
p53 mutations
p53 tumor suppressor gene
p57kip2
Pacak-Zhuang Syndrome
Pacritinib (Vonjo)
Pafolacianine (diagnostic agent during surgery)
Pain (if spread and pressing on nerves/organs)
Pain (in adults)
Pain (less common, due to organ impingement)
Pain (often reproduced by cold water)
Pain (often worse at night and at rest)
Pain (often worse at night, intermittent, varying intensity, long-standing)
Pain (when large enough)
Pain above the stomach
Pain after surgery
Pain and swelling around lymph nodes (abdomen or groin)
Pain around the stomach (heartburn-like)
Pain at the site of the tumor
Pain behind the breastbone
Pain behind the breastbone (heartburn-like)
Pain during sex
Pain during sexual intercourse
Pain during sexual intercourse (dyspareunia)
Pain during urination
Pain following alcohol consumption
Pain in any area of the breast
Pain in face
Pain in lower back, hips, or pelvis
Pain in the abdomen
Pain in the abdomen or pelvis
Pain in the anterior region of the neck
Pain in the area around the anus
Pain in the back
Pain in the breast
Pain in the groin or vaginal area
Pain in the lower femur or below the knee (in active teenagers)
Pain in the mandible (lower jaw)
Pain in the pelvis
Pain in the right upper quadrant of the abdomen
Pain in the side that does not go away
Pain in the trapezius muscle
Pain medication
Pain or bleeding during or after sexual intercourse
Pain or discomfort (numbness, burning, pins and needles)
Pain or discomfort in a testicle or in the scrotum
Pain or feeling of fullness below the ribs
Pain or fullness below the ribs on the left side
Pain or ringing in the ears
Pain or soreness (as tumor presses against nerves and muscles)
Pain reliever (acetaminophen)
Pain that radiates from the throat to the ears
Pain under the rib cage
Pain when swallowing
Pain when swallowing (odynophagia)
Pain while urinating
Pain, itching, ulceration, redness around the site, or bleeding at the site (melanoma)
Pain, swelling, or lumps in the abdomen
Pain, swelling, or pressure in the abdomen or pelvis
Pain, trouble swallowing, or swelling of the neck or face (if spread beyond mesothelium)
Painful ejaculation
Painful lesion that itches or burns
Painful sore in the mouth or throat
Painful swallowing (odynophagia)
Painful swelling due to lymph and blood flow blockage
Painful urination
Painless lump or swelling
Painless lump or swelling in either testicle
Painless, bluish lumps under the skin
Painless, palpable abdominal mass
Painless, raised, shiny skin area with small blood vessels
Painless, slowly enlarging masses in muscle, skin, or non-cutaneous areas
Painless, swollen lymph nodes (neck, underarm, groin)
Painless, tender, or itchy lesions
Painlessness (often)
PALB2 mutations
Pale skin
Palliative care
Palliative care (for recurrence)
Palliative management (for high-grade astrocytomas)
Palliative surgery (for bowel obstruction)
Palliative surgery (for metastatic disease)
Pallor from anemia
Palpable abdominal mass
Palpable lumps
Palpable mass
Palpable mass (primary breast angiosarcoma)
Palpable swollen lymph nodes in the neck
Palpable testicular mass
Palpation of the Bartholin's glands
Palpation of the neck and supraclavicular fossa for cervical adenopathy
Palpation or biopsies of lymph nodes (para-aortic, iliac, inguinal)
Palpitations (Conn syndrome)
Pancreatic islet adenomas
Panendoscopy (quadoscopy)
Pap test
Papillae and solid areas (in borderline and malignant tumors)
Papillary carcinomas of the breast (in situ, encapsulated, solid-papillary, invasive)
Papillary RCC
Papillary thyroid cancer
Papillary tumors
Papules or plaques
Paracentesis or ascitic drain (for ascites)
Paraganglioma (PGL)
Paralysis of facial muscles
Paralysis of the face
Paranasal sinus and nasal cavity cancer
Paranasal sinus paraganglioma
Paraneoplastic blood clotting
Paraneoplastic syndromes (endocrine, neurological, mucocutaneous, hematological)
Paraoccupational secondary exposure to asbestos
Paraosteal OS
Paraplegia (complication)
Parathyroid tumors
Parenchymal angiosarcoma
Parental factors around conception and during gestation (occupation, smoking, alcohol consumption, medicinal drug use, birth factors)
Parental use of cocaine
Parental use of marijuana
PARP inhibitors (olaparib, rucaparib, niraparib)
Partial paralysis
Partial removals (for large tumors)
Particle beam therapy
Passing blood with bowel movements
Past Epstein-Barr virus (EBV) infection
Past radiation therapy to the pelvis
Past radiation therapy to the pelvis (for uterine sarcoma)
Past treatment with radiation therapy to the pelvis
Pathogenic Escherichia coli (producing colibactin)
Pathogenic Escherichia coli producing colibactin
Pathologic assessment (SEE-FIM Protocol)
Pathologic fracture (unexplained broken bone)
Pathological examination (cytological or genetic analysis of tumor tissue)
Pathological examination of biopsy or resected tissue
Pathological examination of nephrectomy specimen
Pathological examination of removed tissue
Pathological examination of tissue
Pathological examination of tissue under a microscope
Pathologically high levels of monoclonal plasma cells in bone marrow
Pathologist examination of biopsy
Pathology (histology/histopathology)
Pathology dissection protocols such as the SEE-FIM Protocol (for identifying early serous cancers and precancers in the fallopian tube)
Paucicellular variant
PCA3 urine test
PCR for BCR-ABL1
PD-L1
Pediatric ependymoma
Pedicled skin flap
Pellagra (due to niacin deficiency)
Pelvic cramping
Pelvic exam
Pelvic exenteration (for radiation-treated recurrence)
Pelvic irradiation
Pelvic pain or discomfort
Pelvic pressure
Pelvic radiation
Pelvic ultrasound (transvaginal or otherwise)
Pembrolizumab (adjuvant setting for clear cell RCC)
Pemigatinib (Pemazyre)
Penile injury (small tears and abrasions)
Pentostatin (purine analog, first-line therapy)
People with light skin
Peptide directed radiotherapy (PRRT) (e.g., 177Lu-Dotatate, 90Y-Edotreotide)
Percutaneous ethanol injection
Performing open-mouthed kissing or oral/mouth-genital sex on a person with HPV
Perfusion Magnetic Resonance Imaging (pMRI) (with gadopentetate dimeglumine contrast)
Perfusion MRI (for tumor blood flow)
Pericardiocentesis (for pericardial effusion)
Perihilar cholangiocarcinoma (Klatskin tumor)
Perinatal transmission of HBV/HCV
Periosteal OS
Peripheral edema
Peripheral neuroblastic tumors (pNTs)
Peripheral PNET
Peritoneal biopsies
Peritoneal irritation (in children/adolescents)
Persistent cough
Persistent ear ache
Persistent earache
Persistent headache (brain metastases)
Persistent rough patch with ulceration and raised border
Persistent trophoblastic disease (PTD)
Personalized mRNA vaccines
Pesticide exposure (tentative)
PET scan
PET scan (for staging)
PET scan (positron emission tomography scan)
PET-CT fusion imaging
PET/CT scanning (for suspected recurrence)
PET/MR
PET/MR scan
Petechiae (tiny red dots under the skin due to bleeding)
Petechiae (tiny red dots under the skin)
Petrochemicals (such as benzene)
Pheochromocytoma-like hypersecretion of catecholamines (rare)
Philadelphia chromosome (t(9;22)(q34;q11.2) translocation)
Phototherapy for neonatal jaundice (questionable association)
Physical exam
Physical exam (checking neck for swelling, lumps)
Physical exam (clinical breast exam)
Physical exam (including clinical breast exam)
Physical exam of the abdomen (for enlarged spleen or liver)
Physical exam of the affected area
Physical exam of the area
Physical exam of the area (head and neck cancer)
Physical exam of the lips and mouth
Physical examination (checking for lumps, lymph node enlargement)
Physical examination (digital rectal exam, pelvic exam)
Physical examination (including pelvic exam)
Physical examination of throat and neck
Physical exercise
Physical exercises
Physical trauma to esophagus
PI3KCA
PI3KCB
PIK3CA mutations
Pilocytic astrocytoma (WHO Grade I)
Pineal AT/RT
Pineal gland tumors
Pink, red, or fleshy color (amelanotic melanoma)
Pink, red, or fleshy colored moles (amelanotic melanoma)
Pinpoint spots under the skin caused by bleeding (petechiae)
Pituitary apoplexy (sudden hemorrhage or necrosis)
Pituitary gland tumors
Pituitary incidentalomas
Pituitary tumors
Plaque therapy (brachytherapy)
Plasma methoxytyramine
Platinum-based chemotherapy (cisplatin, carboplatin, oxaliplatin)
Pleomorphic (giant cell)
Pleomorphic anaplastic neuroblastoma
Pleomorphic undifferentiated sarcoma (formerly Malignant fibrous histiocytoma)
Pleomorphic xanthoastrocytoma (WHO Grade I)
Pleural effusion (complication)
Pleural effusion (due to lung metastasis)
Pleural effusion (fluid around the lung)
Pleurodesis (using talc to scar pleura)
Pleurodesis (using talc)
Pneumothorax (collapsed lung)
Pneumothorax (due to lung metastasis)
POEMS-associated MCD
Point-based algorithm (International Society for Cutaneous Lymphomas, 2005)
Polyembryoma
Polymorphous low-grade adenocarcinoma
Polyomaviruses infection (e.g., Merkel cell polyomavirus)
Polypoid melanoma
Poor diet
Poor diet (e.g., high in processed/barbecued meats, pickled vegetables; low in fresh foods)
Poor diet (low fresh foods, high processed/barbecued meats, pickled vegetables)
Poor hygiene
Poor immune function
Poor immune function (e.g., from medications or HIV/AIDS)
Poor immune system function
Poor nutrition
Poor oral hygiene
Poor spatial perception
Poorly differentiated neuroendocrine carcinomas (large cell, small cell)
Poorly differentiated thyroid cancer
Portal vein embolization (PVE)
Positional vertigo
Positive family history (for FAP patients)
Positron emission tomography (PET) (for metastasis evaluation)
Positron emission tomography (PET) scan
Positron Emission Tomography (PET) scan (using radiolabelled substances like FDG)
Positron emission tomography (PET) scanning
Positron-emission tomography (PET)
Possible correlation with herbicides (extrapolated from other chronic B-cell leukemias/lymphomas)
Possible correlation with pesticides
Post-mastectomy status
Post-menopausal bleeding (for uterine serous carcinoma)
Post-menopausal women
Posterior fossa ependymoma (Infratentorial ependymoma)
Posterior Fossa Group A Ependymoma (molecular subtype)
Posterior Fossa Group B Ependymoma (molecular subtype)
Postmenopausal status
Postmenopausal status (for uterine serous carcinoma)
Pounding of the heart
PPAR-γ
Precocious puberty (in children, Virilization)
Prefibrotic primary myelofibrosis
Pregnancy (may accelerate tumor growth due to progesterone receptor expression)
Pregnancy test (to detect high levels of chorionic gonadotropin)
Prenatal exposure to diethylstilbestrol (DES)
Presence of >2 billion plasma cells per liter of blood
Presence of >20% of nucleated blood cells being plasma cells
Presence of a nevus (for melanoma development)
Presence of neuroendocrine tumors (occurs in approximately 10% of all, or 30–40% of more advanced/well developed NETs)
Presence of primary cancer in other organs (e.g., Lung, Breast, Thyroid, Kidney, Prostate)
Presence of pseudo-lipoblasts in a myxoid sarcoma-like background
Presence of squamoid nests
Pressure effects on muscles and optic nerve
Pressure in the area around the anus
Preventive mastectomy
Previous bladder cancer
Previous GTD
Previous history of cervical cancer
Previous myeloproliferative disorders (polycythemia vera, essential thrombocythemia)
Previous testicular cancer
Previous treatment for cervical cancer
Previous treatment for testicular cancer
Previously having ovarian cancer
Primary bilateral macro nodular adrenal hyperplasia (bilateral)
Primary cardiac angiosarcoma
Primary cutaneous adenoid cystic carcinoma
Primary cutaneous angiosarcoma
Primary Intraocular Lymphoma (Non-Hodgkin's, B-cell type, T-cell type)
Primary liver angiosarcoma
Primary lymphomas of the appendix
Primary peritoneal cancer
Primary plasma cell leukemia
Primary tumors
Prior history of pre-invasive or invasive cervical cancer
Prior radiation therapy (general for soft tissue sarcomas)
Prior skin cancers (e.g., multiple myeloma, chronic lymphocytic leukemia, malignant melanoma)
Prior surgery (for recurrence)
Problems caused by the production of too many hormones
Problems or pain with swallowing
Problems urinating (weak stream, difficulty starting, frequent urination, nocturia, pain or burning during urination)
Problems with balance or walking
Problems with bowel function
Problems with thinking
Problems with thinking or memory
Procedure to collect cells
Production of TAZ-TEAD transcriptome
Progesterone receptor-positive (PR+)
Prognostic multigene classifier
Progression from parathyroid adenoma
Progressive development of genetic abnormalities leading from monoclonal gammopathy of undetermined significance to smoldering multiple myeloma, overt myeloma cancer, and ultimately secondary PCL
Progressive paraplegia (spinal tumor)
Progressive spastic weakness in legs
Progressive worsening cough
Prolonged exposure to ultraviolet (UV) radiation
Prolonged exposure to ultraviolet (UV) radiation from the sun
Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning devices
Prolonged irritations of the urethra due to urinary catheterization
Prolonged sedentary time
Proneural
Prostate tumor with neuroendocrine differentiation
Prostate-specific antigen (PSA) blood test
Proteasome inhibitor drugs (e.g., bortezomib)
Proteasome inhibitors (e.g., bortezomib, carfilzomib, ixazomib)
Proton beam irradiation
Proton radiation treatment
Proton therapy
Protuberance (bump) (often delayed)
Pruritus (itchy skin)
PSA test
Psammomatous
Pseudoglandular (adenoid)
Pseudosarcomatous reaction to epithelial malignancy (Composition hypothesis)
Psychiatric care
Psychological distress
Psychological interventions (psychoeducation, cognitive behavioral therapy)
Psychosocial intervention
Psychosocial interventions (e.g., talk therapy, support groups)
Psychosocial programs
Psychotic episodes
PTEN gene mutations (associated with Cowden syndrome)
Pulmonary paraganglioma
Purple discoloration of the extremity
Purple lines on abdomen (Cushing's syndrome)
Purplish-red papule (cutaneous)
Pyrrolizidine alkaloid exposure
QCancer algorithm
Quantitative chorionic gonadotropin (hCG) levels
R-CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab)
R-CHP with polatuzumab vedotin
RAD51L3
Radiation (if UCD treatments not effective)
Radiation emergency exposure
Radiation exposure (especially to the scalp)
Radiation exposure to breast/chest (especially before age 30)
Radiation exposure to the head and neck
Radiation exposure to the head and neck (for salivary gland cancer)
Radiation therapy (e.g., upfront radiation, conformal local radiation, external beam radiation, proton beam radiation)
Radiation therapy (external beam radiotherapy)
Radiation therapy (external beam radiotherapy, brachytherapy)
Radiation therapy (external beam, brachytherapy)
Radiation therapy (external beam, proton beam, stereotactic radiosurgery)
Radiation therapy (for seminomas)
Radiation therapy (head and neck cancer)
Radiation therapy (in dogs)
Radiation therapy (including 3D conformal radiation therapy, intensity-modulated radiation therapy, particle beam therapy, brachytherapy)
Radiation therapy (intensity-modulated radiation therapy, brachytherapy, external beam radiotherapy)
Radiation therapy (photon-beam, proton-beam, fractionated external beam)
Radiation therapy (radiotherapy, external beam radiation therapy, whole-brain radiotherapy treatment/WBRT, whole-brain irradiation, radiosurgery, stereotactic radiosurgery, Gamma knife, Cyberknife, Novalis Tx radiosurgery, brachytherapy, proton therapy, hypofractionated radiation therapy, postoperative radiotherapy)
Radiation therapy (RT) (if clear resection margins not achieved or for advanced disease)
Radiation therapy to the breast or chest
Radiation treatments to the head or neck as a child
Radical complete vulvectomy
Radical mastectomy (historical cause)
Radical partial vulvectomy
Radical radiotherapy
Radical surgical resection with a 2 cm margin
Radioactive compounds (radium-223, samarium-153-EDTMP)
Radioactive iodine uptake test
Radiofrequency ablation (palliative)
Radiographic imaging (CT scan or MRI)
Radionuclide therapy (177Lu-DOTA-TATE)
Radionuclide Therapy (Iodine-131 meta-iodobenzylguanadine - MIBG, Peptide Receptor Radionuclide Therapy - PRRT)
Radiosurgery (stereotactic radiosurgery)
Radiotherapy
Radiotherapy (for metastatic disease)
Radiotherapy (RT)
Radiotherapy for unrelated conditions
Radiotherapy to the abdomen
Radon in the home or workplace
Ragged, blurred, or irregular border of a mole
Raised area with ulceration
Raised red blood cell volume (rare)
Raised, smooth, pearly bump on sun-exposed skin (BCC)
Rapid breast swelling
Rapid growth spurts during puberty
Rapid strep test
Rapidly enlarging tumors
Rapidly enlarging, firm mass in extremity tissue
Rapidly growing, non-tender red, purple, or skin-colored bumps (Merkel cell carcinomas)
RAS (NRAS, HRAS, KRAS)
RAS mutant subtype
RasGTPase
Rb
RB
RB gene
RB1 (associated with Retinoblastoma)
RB1 (gene for tumor suppressor protein pRb)
Re-operation after incidental cancer diagnosis
Recent onset of diabetes
Receptive anal sex
Reciprocal translocation between chromosomes 11 and 22, t(11;22)
Reconstructive surgery (skin grafts, skin flaps)
Rectal bleeding
Recurring ear infections
Red and irritated eye
Red and painful eye
Red hair
Red or purple skin lumps
Red or white patches in the mouth
Red patch (similar to eczema)
Red, purple, or brown skin lesions (nodules or blotches)
Red, scaling, thickened patch on sun-exposed skin (SCC)
Red, scaly nipple or skin
Red, swollen tonsils
Redness and irritation on the penis
Redness and swelling of overlying skin
Reduced back flexibility
Reduced DNA repair capacity
Reduced microbial diversity in tumors
Reduction of immunosuppressive drugs
Refractory anemia with excess blasts (RAEB-I, RAEB-II)
Refractory anemia with ring sideroblasts (RARS)
Regular check-ups
Regular checks of eye nevi
Regular consumption of very hot drinks
Regular coughing (lung metastases)
Regular monitoring (for small tumors)
Regurgitation of food
Rehabilitation (physical therapy, dietary counseling, speech therapy for head and neck cancer)
Rehabilitation (speech and language therapy)
Release of biologically active substances (serotonin, histamine, tachykinins, kallikrein, prostaglandins) by neuroendocrine tumors
Removal of parathyroid tumors
Removal of pheochromocytomas
Renal cell cancer (RCC)
Renal dysfunction (iMCD-TAFRO)
Renal insufficiency (impaired kidney function)
Renovation or DIY activities in buildings with asbestos
Renovation or DIY activities in buildings with asbestos-containing materials
Reproductive history increasing estrogen exposure (early menstruation, late or no first birth, late menopause)
Reproductive history leading to increased estrogen exposure (early menstruation, late first birth, late menopause)
Reproductive history leading to more estrogen exposure (early menstruation, late first birth, late menopause)
Resembles a bruise, birthmark, or pimple
Respiratory changes
Restricted movement
RET oncogene mutations
RET proto-oncogene
Retroperitoneal desmoid tumor
Retroviral replicating vectors (experimental, Toca 511 & Toca FC)
Rhabdoid
Rhabdoid variant
RhoC GTPase
Right-sided cardiac valve disease
Rigors (rare, constitutional symptom)
Ringing in ears
Ringing in ears (tinnitus)
Ringing in the ears
Risk of Malignancy Index (RMI)
Risk of Ovarian Cancer Algorithm (ROCA)
Risk-reducing salpingo-oophorectomy (preventive surgery for high-risk individuals)
Rituximab (anti-CD20 monoclonal antibody, often combined with purine analogs)
Rituximab (for nodular lymphocyte-predominant subtype)
Rituximab (for UCD with compression symptoms, first-line for HHV-8-associated MCD, also used for iMCD if siltuximab ineffective)
Romidepsin (Istodax)
Rouleaux formation of red blood cells
Round, elevated, reddish, and sometimes ulcerated mass (when found in skin)
Routine laboratory studies
Ruxolitinib (Jakafi)
S-100 protein marker
Salivary biomarkers (investigational)
Salpingectomy (removal of fallopian tubes)
Salted, smoked, or pickled foods
Salted, smoked, or pickled foods consumption
Saltwater gargles
Salvage therapy (cisplatin, ifosfamide, paclitaxel)
SAMD9/9L syndromes
Sarcoma botryoides (rhabdomyosarcoma)
Sarcomatoid variant
Scaly, red, or swollen skin (nipple/breast)
Scaly, red, or swollen skin in the nipple area or breast
Scar tissue
Schistosomiasis (infection with Schistosoma haematobium)
Sclerosing DFSP
Sclerosing stromal tumors
Screening for precancer cells
Scrotal or vaginal mass
SDHx
Sebaceous Carcinoma (eyelid)
Sebaceous-cell tumors
Second curettage (for persistent trophoblastic disease)
Second look laparotomy
Secondary breast angiosarcoma
Secondary myelofibrosis (post-essential thrombocythemia)
Secondary myelofibrosis (post-polycythemia vera)
Secondary tumors (metastatic tumors)
Secondary tumours
Secondhand smoke
Secretion of catecholamines (in 1-3% of cases)
Seizures (brain metastases)
Selective inhibitor of nuclear export (e.g., selinexor)
Self-care (e.g., aerobic exercise)
Self-help groups
Sensitivity to cold weather
Sensitivity to light
Sensory disturbances (e.g., abnormal facial sensation)
Sentinel lymph node (SLN) dissection
Serotonin–norepinephrine reuptake inhibitors
Serous psammocarcinoma
Serrated polyposis syndrome
Sertoli-Leydig cell tumor (arrhenoblastoma)
Serum carcinoembryonic antigen (CEA) levels
Serum tumor marker test (elevated alpha-fetoprotein, human chorionic gonadotropin, lactate dehydrogenase, alkaline phosphatase, cancer antigen 125)
Sestamibi parathyroid scan (intense radioactivity, no washout)
Severe abdominal pain (in children/adolescents)
Severe disfigurement
Severe lymphedema
Sexual precocity (ovarian)
Sexual transmission of KSHV (e.g., deep kissing)
Shiny, pearly skin nodule
Shortness of breath (distant spread, lung metastases)
Shortness of breath (dyspnea)
Shunt (for hydrocephalus/intracranial pressure)
Sialadenoma papilliferum
Signs and symptoms of hyperthyroidism
Siltuximab (FDA-approved, first-line for iMCD)
Simian virus 40 (SV40) infection (cofactor)
Simple repair with sutures
Single nucleotide polymorphisms (SNPs)
Single-photon emission computed tomography (SPECT)
Sirolimus (if siltuximab not effective for iMCD)
Sirolimus (rapamycin)
Sister Mary Joseph Nodule
Sister Mary Joseph nodule (metastasis)
Sitting regularly for prolonged periods
Skin biopsy (excisional, incisional, punch)
Skin breakdown on a mole
Skin breakdown with fungating lesions
Skin changes
Skin changes (peau d'orange, dimpled appearance)
Skin changes in the vulva (rash or warts)
Skin hyperpigmentation (in males)
Skin mucinous carcinoma
Skin rash (liver metastases)
Skin sarcomas (e.g., angiosarcoma, dermatofibrosarcoma protuberans, Kaposi's sarcoma, leiomyosarcoma)
Skin that is paler than usual
Skin thickening
Skin thickening on the glans or inner foreskin
Sleep problems
Slow-growing tumor
Slowly enlarging masses
Slurring of speech
Small blood vessels visible within the tumor (BCC)
Small cell lung cancer (SCLC)
Small cell OS
Small supernumerary marker chromosome
Small-cell carcinoma
Small-cell ovarian carcinoma (hypercalcemic, pulmonary)
Smegma accumulation
Smoking (cigarette smoking, wood fires)
Smoking (current smokers: relative risk 2.22, past smokers: relative risk 2.02)
Smoking (evidence unclear)
Smoking (mucinous ovarian cancer)
Smoking cocaine
Smoking duration (relative risk per 20 years: 1.44)
Smoking tobacco (active and passive)
Soaking night sweats
Soft foods
Soft tissue plasma cell tumors (plasmacytomas)
Soft tissue tumours
Solid pattern adenocarcinoma
Somatic amplification of MYCN oncogene
Somatic mutation in JAK2, CALR, or MPL genes
Somatic mutation in the FOXL2 gene (c.402C>G, p.C134W) in adult granulosa cell tumours
Somatic mutations of AKT1 (in-frame duplications in the pleckstrin-homology domain or point mutations) in juvenile granulosa cell tumours
Somatostatin analogs (Octreotide, Lanreotide)
Somatostatin receptor scintigraphy (SRS or SSRS)
Some liver diseases
Sonic Hedgehog
Sonic Hedgehog pathway activation
Sonography (ultrasound)
Sore in the mouth or throat (head and neck cancer, not glomus tumor)
Sore in the mouth or throat that does not heal
Sore in the mouth or throat that does not heal and may be painful
Sore that does not heal (BCC)
Sore throat or feeling that something is caught in the throat
Sore throat that does not go away
Sore throat that does not go away (head and neck cancer, not glomus tumor)
Sore tongue
Soreness localized to the area of the tumor or extremity
Sores, lumps, or ulcers on the vulva that do not go away
Spayed/neutered dogs
Specific high-risk HPV types (e.g., 16, 18, 31, 45)
Speech difficulties (e.g., decreased production, difficulty speaking, poor language interpretation)
Speech may become slurred
Speech problems
Speech, vision, memory, or behavioral disruptions (brain metastases)
Spending a lot of time in the sun
Spermatocytic tumor
Sphenoid wing meningioma
Spinal AT/RT
Spindle cell tumors
Spindle-cell/sclerosing rhabdomyosarcoma
Splenectomy (may be used when other therapies fail and spleen has high disease burden)
Splenectomy (surgery to remove the spleen)
Splenomegaly (enlargement of the spleen)
Sporadic medullary thyroid cancer
Sporadic occurrence
Sporadic VS (unilateral, non-hereditary)
Spread to other tissues (in aggressive forms)
Squamoid variant
Squamous Carcinoma (eyelid)
Squamous cell carcinoma (epidermoid carcinoma)
Squamous-cell carcinoma (basaloid, warty, mixed warty-basaloid, verrucous, papillary, other SCC mixed, sarcomatoid carcinomas)
Squamous-cell skin cancer (SCC)
Squint (strabismus)
Stage I NSCLC
Stage II NSCLC
Stage III NSCLC
Stage IV NSCLC
Staging (imaging workup)
Staging (TNM staging guidelines)
Staging (TNM system)
Staging (TNM system, Cambridge Prognostic Group)
Staging according to cell appearance, dimensions, and extent
Staging based on clinical and radiologic examination
Staging tests (imaging, sentinel lymph node biopsy)
Staging tests (to determine spread)
Staining for latency-associated nuclear antigen (LANA-1) to detect HHV-8 infection
Standard surgical excision
Starting menstruation at an early age
Starting sex at a young age
Stem cell transplant (bone marrow transplant)
Stem cell transplantation
Stem cell transplantation (autologous and allogeneic)
Stem-cell transplantation
Stent in the stomach
Stenting of bile ducts
Stenting procedures
Stereotactic surgery
Steroid supplementation (hydrocortisone, fludrocortisone)
Steroids
Stomach discomfort
Stomach inflammation
Stomach region pain (heartburn-like)
Stool DNA screening testing (FIT-DNA)
Stool tests (e.g., Fecal occult blood testing (FOBT), Fecal immunochemical test (FIT), FIT-DNA)
Strabismus (crossed eyes)
Streptococcus gallolyticus association
Stressful procedures (anesthesia, surgery, radiation treatment) can trigger carcinoid crisis
Stretch marks (striae)
Stridor (high-pitched wheezing sound)
Strontium-89 chloride (for pain)
Stumbling gait
Subependymal giant cell astrocytoma (WHO Grade I)
Substantial breast swelling and redness (inflammatory breast cancer)
Substernal chest pain
Succinate Dehydrogenase Subunit x (SDHx) genetic variants
Suction curettage
Sudden build-up of fluid in the scrotum
Sudden fracture with minor trauma
Sudden hearing loss
Sudden onset headache
Sudden or frequent urge to urinate
Sun exposure (for lip cancer)
Sun exposure (leading to DNA damage like thymine dimers)
Sun tanning beds
Sun-damaged skin (associated with collision tumor hypothesis)
Superficial basal-cell carcinoma
Superficial spreading melanoma
Superior vena cava syndrome (complication of cardiac angiosarcoma)
Supplemental oxygen
Supportive and palliative care
Supportive care (e.g., antiemetics, cold caps, antidepressants, physical therapy, CBT, yoga, peer support)
Supportive care (e.g., red blood cell transfusions, erythropoietin)
Supportive care (nutrition, dental care)
Supportive therapy
Supportive treatment (physical exercises)
Supratentorial AT/RT
Surgery (complete surgical removal)
Surgery (curative for benign tumors, likely curative for other low grade tumors)
Surgery (e.g., endoscopic resection, partial colectomy, proctocolectomy, radiofrequency ablation, cryosurgery, removal of metastases, cytoreductive surgery, intestinal bypass, stent placement)
Surgery (e.g., esophagectomy, endoscopic mucosal resection)
Surgery (e.g., gastrectomy, endoscopic mucosal resection, endoscopic submucosal dissection)
Surgery (e.g., Limb amputation, Limb sparing surgery, Bone graft, Artificial bone replacement, Limb salvage prostheses, Allograft, Tumor-devitalized autograft, Vascularized fibula graft, Distraction osteogenesis, Custom-made implants)
Surgery (esophagectomy)
Surgery (excision, ablation, hysterectomy, radical hysterectomy, trachelectomy, exenteration)
Surgery (excision, wide local excision, Mohs surgery)
Surgery (first-line for Unicentric Castleman disease)
Surgery (for diagnosis and removal)
Surgery (for localized skin lesions)
Surgery (for primary tumors)
Surgery (gastrectomy, endoscopic mucosal resection, endoscopic submucosal dissection)
Surgery (head and neck cancer)
Surgery (including Mohs surgery)
Surgery (inguinal orchiectomy)
Surgery (limb salvage or amputation)
Surgery (mastectomy, lumpectomy)
Surgery (mastectomy, lumpectomy, partial mastectomy, breast-conserving surgery, sentinel lymph node biopsy, breast reconstruction)
Surgery (mastectomy, modified radical mastectomy)
Surgery (microsurgery)
Surgery (nephrectomy)
Surgery (often unresectable, but curative if resectable and followed by adjuvant therapy)
Surgery (Open excision, Electro-resection with flash, Laser surgery, Cystourethrectomy, Cystoprostatectomy, Anterior body cavity, Incomplete or basic penectomy surgery)
Surgery (partial or complete kidney removal)
Surgery (partial or full removal of the tumour)
Surgery (partial surgical resection)
Surgery (pleurectomy/decortication, extrapleural pneumonectomy, pericardectomy)
Surgery (radical cholecystectomy, extended cholecystectomy, hepatectomy)
Surgery (radical prostatectomy)
Surgery (resection, gross total resection, cytoreduction/debulking, minimally invasive techniques, trans-nasal trans-sphenoidal approach, craniotomy)
Surgery (resection, liver transplantation)
Surgery (surgical removal/decompression)
Surgery (surgical resection, laparoscopic adrenalectomy, open procedure)
Surgery (Thyroidectomy)
Surgery (to remove cancer)
Surgery (to remove tumor)
Surgery (total abdominal hysterectomy, removal of ovaries, tubes, uterus, cervix, omentum removal, lymph node sampling)
Surgery (total thyroidectomy with bilateral neck dissection)
Surgery (trans-sphenoidal adenectomy)
Surgery (tumor removal/resection)
Surgery (Whipple procedure, distal pancreatectomy)
Surgery (wide excision, Mohs surgery)
Surgery (wide local excision, microsurgery, laser surgery, circumcision, amputation/penectomy)
Surgery to remove cancer
Surgery to remove the tumor
Surgical discovery (coincidental)
Surgical excision (benign glomus tumors)
Surgical exploration (laparoscopy, laparotomy)
Surgical exploration (Laparoscopy, Laparotomy)
Surgical removal
Surgical removal of the tumor
Surgical removal with clean margins
Surgical resection
Surgical resection (en bloc)
Surgical resection (radical)
Surgical resection of any residual disease (for nonseminomatous tumors)
Surgical resection with permanent colostomies (historically)
Surgical resection with wide margins
Surgical staging (FIGO staging guidelines)
Surgical valve repair or replacement (for carcinoid heart disease)
Survival of five or more years post-mastectomy
Sutent
Swelling around the tumor
Swelling at the site of the tumor
Swelling in the abdomen
Swelling in the abdomen or pelvis
Swelling in the face and/or veins in the neck
Swelling in the mouth
Swelling of lymph nodes (under the arm or in the neck)
Swelling of the arm
Swelling of the jaw
Swelling of the neck or face
SWI/SNF
SWI/SNF mutations/deletions
Swollen abdomen
Swollen glands in the neck
Swollen legs
Swollen lymph nodes (distant spread)
Swollen lymph nodes in the neck
Swollen stomach
Swollen, painless lymph nodes
Swollen, painless lymph nodes (lymphadenopathy)
Symptomatic control with somatostatin analogues (octreotide, lanreotide, pasireotide)
Symptomatic treatment (anticonvulsants for seizures, steroids for brain swelling)
Symptomatic treatment (e.g., blood transfusions)
Symptoms depend on the type of cancer
Symptoms due to compression of surrounding structures by enlarged lymph nodes
Symptoms from distant metastases (e.g., brain)
Symptoms like those of infections
Symptoms may not be present until cancer is advanced
Symptoms of increased intracranial pressure
Symptoms of inflammatory systemic illness
Symptoms of sinusitis
Symptoms related to HIV infection (HHV-8-associated MCD)
Symptoms similar to infections
Symptoms similar to stroke
Symptoms vary depending on location and size of the cancer
Synaptophysin (P38)
Syndromic Wilms' tumor
Systemic (intravenous) methotrexate (for hydatidiform mole)
Systemic chemotherapy (e.g., cisplatin, gemcitabine, methotrexate, vinblastine, doxorubicin, carboplatin, vinflunine, paclitaxel, pemetrexed)
Systemic T cell lymphoma of childhood
Systemic therapy (prior to surgery)
Sézary syndrome
T1- and T2-weighted MRI with heterogeneous enhancement
T2*-weighted imaging (MRI)
Tachycardia (fast heart rate)
Taking tamoxifen
Talc exposure
Talc exposure (controversial)
Taller height
Tamoxifen (for endometrial stromal sarcomas)
Tamoxifen therapy
Tamoxifen use
Tanning bed use
Tape stripping
Targeted therapy (being studied)
Targeted therapy (BRAF inhibitors, MEK inhibitors, C-Kit inhibitors, NRAS inhibitors)
Targeted therapy (e.g., Bevacizumab, Aflibercept, Cetuximab, Panitumumab)
Targeted therapy (e.g., BRAF inhibitors, MEK inhibitors)
Targeted therapy (e.g., CDK4 or MDM2 gene inhibitors like abemaciclib, ribociclib, milademetan)
Targeted therapy (e.g., Dostarlimab)
Targeted therapy (e.g., HER2-targeted antibodies, PARP inhibitors, PIK3CA inhibitors)
Targeted therapy (e.g., Rituximab)
Targeted therapy (e.g., sorafenib, atezolizumab, nivolumab, pembrolizumab, regorafenib)
Targeted therapy (e.g., sorafenib, lenvatinib, regorafenib, cabozantinib, ramucirumab)
Targeted therapy (e.g., trastuzumab for HER2-overexpressing cancer)
Targeted therapy (e.g., trastuzumab for HER2-overexpressing tumors)
Targeted therapy (e.g., trastuzumab for HER2-positive tumors)
Targeted therapy (erlotinib, everolimus, sunitinib)
Targeted therapy (Erlotinib, Infigratinib (Truseltiq), Pemigatinib (Pemazyre), Ivodesinib (Tibsovo), Futibatinib (Lytgobi))
Targeted therapy (head and neck cancer)
Targeted therapy (protein kinase inhibitors like Vandetanib, Cabozantinib)
Targeted therapy (Tyrosine Kinase Inhibitors - TKIs, Belzutifan, Selpercatinib)
Targeted therapy (under investigation)
Tartrate resistant acid phosphatase (TRAP) stain
Taste changes
Taxol (Paclitaxel)
TAZ
Telangiectatic OS
Temporary memory loss
Tender skin nodule in the extremity
Tenderness (when large enough)
Terahertz spectroscopy
Teratoma (immature, mature/dermoid cyst)
Teratoma (mature teratoma, immature teratoma)
TERT promoter
Testes NETs
Testicular cancer (as a presentation in males)
Testicular lump
Testing for copper deficiency
Testing for Ebstein Barr virus
Testing for HPV status
Testing hormone levels
Tests done after miscarriage or abortion
Tests of blood, urine, or saliva for hormone levels
Tests of vision, balance, coordination, and mental status
TGF-β
Therapeutic radiation exposure to the head
Therapy exercises (speech, voice, swallow)
Therapy to remove proteins from the blood (plasmapheresis)
Therapy-induced immunosuppression
Thermal ablation (Radiofrequency ablation, Cryoablation)
Thickening of the heart valves
Thinning, fragile skin (Cushing's syndrome)
Thoracentesis or tube thoracostomy (for pleural fluid)
Thoracic inlet paraganglioma
Thoracotomy and attempted complete resection (for small, resectable tumors)
Thorough sampling of the tumor
Three-drug regimen (e.g., bortezomib-lenalidomide-dexamethasone)
Throat culture
Throat pain
Throbbing headache
Thrombocytopenia (iMCD-TAFRO)
Thrombocytopenia (low platelet count)
Thrombocytosis (iMCD-IPL)
Thrombopoietin receptor agonists (e.g., romiplostim, eltrombopag)
Thymic carcinoids
Thymus and mediastinal carcinoid tumors
Thyroid hormone therapy
Thyroid scan
Thyroid stimulating hormone (TSH) level measurement
Thyroid tests
Thyroid tumors
Thyroid-stimulating hormone (TSH) levels
Thyrotropinomas
Tinnitus (in glomus tympanicum and jugulare)
Tiredness
Tis21
Tissue biopsies
Tissue biopsy
Tissue biopsy (histopathologic analysis)
Tissue biopsy (stereotactic biopsy or craniotomy with tumor resection)
Tissue sample (biopsy)
Tissue tests
TMPRSS2-ERG urine test
TMZR1-eRNA
TNF-Related Apoptosis Induced Ligand (TRAIL) (under investigation)
TNM classification (staging)
TNM staging (Tumor, Nodes, Metastases)
TNM staging system (AJCC staging system)
Tobacco use (chewing or smoking)
Tobacco use (smoking or chewing)
Tocilizumab (if siltuximab not available for iMCD)
Tongue base mucosectomy
Topical application of T4N5 liposome lotion (for xeroderma pigmentosum)
Topical beta-blockers (e.g., timolol)
Topical chemotherapy (e.g., 5-fluorouracil)
Topical chemotherapy (e.g., imiquimod, 5-fluorouracil)
Topical medications (e.g., fluorouracil, imiquimod)
Torisel
Torque teno virus
Total body photography
Total UV exposure (for squamous-cell skin cancers)
Toxic effects of prior treatments (in secondary PCL)
TP53 (gene for tumor suppressor protein p53)
TPH inhibitor (telotristat ethyl for diarrhea)
Trametinib (MEK inhibitor, in combination with BRAF inhibitors)
Transarterial embolization (preoperative procedure)
Transcatheter arterial chemoembolization (TACE)
Transfusions (red blood cell, platelet)
Transgenerational epigenetic inheritance from hazardous environmental substances (plastics, pesticides, dioxins)
Transient myeloproliferative disease (transient leukemia)
Transitional cell cancer (TCC)
Translocation between chromosomes 12 and 15 (t(12;15)(p13;q25)) resulting in ETV6-NTRK3 fusion gene (in infantile type)
Translocations at t(21;22) and t(7;22)
Translocations involving FUS-DDIT3 or EWSR1-DDIT3 fusion genes in myxoid liposarcoma
Transurethral biopsy
Transurethral resection of bladder tumor (TURBT) for biopsy
Transvaginal ultrasonography (heteroechoic mass with sharp borders and high vascularization)
Trauma
Trauma (for primary tumors)
TRC8/RNF139
Treating with high temperatures
Treatment as other malignant ovarian tumours
Treatment directed at POEMS syndrome (for POEMS-associated MCD)
Treatment for heart failure
Treatment for high grade serous tumors
Treatment for low grade serous tumors
Treatment of H. pylori infection
Treatment of H. pylori infection (for MALT lymphomas)
Triiodothyronine (T3) and thyroxine (T4) level measurement
Trimodality therapy (TURBT + chemotherapy + radiotherapy)
Tripe palms
Triple negative breast cancer (TNBC)
Triple wild-type subtype
Trisomy 8
Trisomy for chromosomes 8, 11, 17, or 20 (in infantile type)
Trouble breathing (if spread and pressing on organs)
Trouble eating or feeling full
Trouble moving mouth or jaw
Trouble opening the mouth
Trouble speaking
Trouble swallowing
Trouble swallowing (dysphagia)
Trouble swallowing (head and neck cancer, not glomus tumor)
Trouble urinating
Trouble walking (ataxia)
Trouble walking (gait change, rotation of feet)
Truncal ataxia
Truncal obesity
Tuberous sclerosis (inherited syndrome)
TUJ1
TUJ1 testing
Tumor biopsy
Tumor growth
Tumor hypercellularity with fibrotic bands
Tumor located in extremity, trunk, or head and neck areas
Tumor marker Cyfra 21-1
Tumor marker labs (e.g., serotonin)
Tumor markers (alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19–9), carcinoembryonic antigen (CEA), cancer antigen 125 (CA125))
Tumor markers (carcinoembryonic antigen, carbohydrate antigen)
Tumor markers (e.g., carcinoembryonic antigen, carbohydrate antigen)
Tumor originating from epithelial cells of the thymus
Tumor protein P53 gene mutations (associated with Li-Fraumeni syndrome)
Tumor suppressor gene dysfunction (p53, WT1)
Tumor suppressor genes
Tumor-infiltrating lymphocytes (TIL therapy)
Tumor-infiltrating lymphocytes (TIL) therapy
Tumors
Tumors of endocrine glands
Tumors on head, neck, extremities, perianal region, or eyelid
Tumour marker (Inhibin)
Twenty-four hour urinary metanephrines
Tylosis with esophageal cancer (RHBDF2 gene mutation)
Type 2 diabetes (contributor)
Type A
Type AB
Type B1
Type B2
Type B3
Typical carcinoid (TC)
Tyrosine-protein kinase SYK
UFT
Ulcer in the mouth that does not heal
Ulcer with crusting
Ulceration and bleeding (SCC)
Ulceration of a mole
Ulceration of mucosa
Ulcerative growth
Ulcering in the skin
Ultrasound (for neck masses)
Ultrasound imaging (hypoechoic mass, invasion of local structures, lymph node metastases)
Ultrasound of liver and biliary tree
Ultrasound of the testicles
Ultrasound of upper urinary tract
Ultrasound scan
Ultrasound screening (every six months for high-risk individuals)
Ultraviolet light (UV) exposure (sun or tanning devices)
Unconsciousness (in advanced stages)
Uncontrollable twitching
Uneven color of a mole (shades of black, brown, tan)
Uneven posture
Uneven pupil size
Unexpected lactation
Unexplained nausea
Unexplained rapid weight loss
Unexplained weight loss
Unfavorable dietary patterns
Unfavorable neuroblastoma
Unintended weight loss (liver-related)
Unintentional weight loss
Unknown (Idiopathic Multicentric Castleman disease)
Unknown cause (general cancer etiology)
Unknown for most cases
Unknown for uterine serous carcinoma, but it is classified as a type II endometrial cancer and does not develop from endometrial hyperplasia or is hormone-sensitive.
Untreated celiac disease
Unusual bleeding
Unusual nipple discharge (sudden, bloody, or unilateral)
Unusual sleepiness
Unusual sleepiness (lethargy)
Unusual vaginal discharge
Unusual vaginal discharge (thin white or clear in postmenopausal women)
Unusual warmth of the affected breast
Unusually heavy flow of blood
Upper abdominal pain
Upper GI series (barium roentgenogram)
Urban living
Urinary catheterization
Urinary diversion (e.g., ileal conduit, continent urinary diversion)
Urinary problems
Urinary tract carcinoid tumor and neuroendocrine carcinoma
Urine 5-hydroxyindoleacetic acid (5-HIAA)
Urine catecholamine levels
Urine tests
Urine tests (e.g., protein electrophoresis for Bence Jones protein)
Urine tests for bladder tumor antigen (BTA)
Urine tests for mRNA of tumor-associated genes
Urine tests for NMP22
Urothelial cell cancers
Use of cannabis
Use of fertility drugs to induce ovulation
Use of hormones and fertility drugs
Use of immunosuppressive medications (e.g., Cyclosporin A, azathioprine)
Usual-type vulvar intraepithelial neoplasia (uVIN)
Usually located on the head and neck (when found in skin)
Uterus filled with pus (pyometrea)
UV light
UV light exposure
UV light treatment for psoriasis
UVA radiation via indirect DNA damage (for melanoma)
UVB radiation via direct DNA damage (for BCC and SCC)
Uveal Melanoma (Choroid Melanoma, Iris Melanoma, Ciliary Body Melanoma)
VAC regimen (vincristine, actinomycin D, cyclophosphamide)
Vaccine-associated sarcoma (in cats)
VAD regimen (vincristine, doxorubicin, dexamethasone)
Vaginal bleeding (irregular or postmenopausal)
Vaginal bleeding (not menstrual bleeding)
Vaginal bleeding that is not your period
Vaginal brachytherapy (VBT)
Vaginal discharge (watery, strong odor, contains blood)
Vaginal germ cell tumors (teratoma, endodermal sinus tumor)
Vaginal lump
Vaginal mass (rare)
Vaginal spotting in postmenopausal women
Values of 0.5 billion or 5% circulating plasma cells (suggested therapeutic criterion)
Various colors from shades of brown to black (melanoma)
Various infections
Vascular tumors of bone (WHO 2020 classification)
VCMP regimen (vincristine, carmustine, melphalan, prednisone alternating with vincristine, carmustine, doxorubicin, prednisone)
VEGFA (gene for vascular endothelial growth factor, associated with over-expression)
VEGFR2
Vemurafenib (BRAF inhibitor, second-line therapy)
Ventriculoperitoneal shunt (for increased intracranial pressure)
Very hot drinks (over 65 °C or 149 °F)
Vesicular stomatitis virus (VSV) therapy (experimental)
Vestibular testing
Vimentin
Vinyl chloride exposure
Viral cause (suspected)
Viral genome integration (HBV)
Virtual colonoscopy
Virtual colonoscopy (CT colonography)
Virtual karyotyping
Visceral lipomas
Visible lumps on the outside of the neck or oral cavity
Visible tumor through the pupil
Vision problems
Vision problems (e.g., poor vision, vision loss, visual abnormalities)
Vision problems (e.g., visual loss, inability to distinguish colors, seeing lines)
Visual field defects (e.g., bitemporal hemianopsia)
Visual field examination
Visual inspection of skin lesion
Visual loss
Vitamin D receptor
Vitamin D supplementation
Voice changes (hoarse)
Voice changes (late stage)
Voice may become hoarse or weak
Voice rehabilitation
Vomiting (liver or brain metastases)
Vomiting (metastatic melanoma)
Vomiting blood
Vomiting too much (hyperemesis)
Von Hippel-Lindau Disease (inherited syndrome)
Von-Hippel-Lindau syndrome (VHL)
Vorinostat (Zolinza)
Vulvar itching or tenderness
WAGR syndrome
Walking difficulties
Warm liquids
Warm, red, and swollen breast
Washing clothing of asbestos workers
Watchful waiting
Watchful waiting (active surveillance)
Watchful waiting (for asymptomatic patients with no significant cytopenia or organomegaly)
Watchful waiting (watch and wait, watch and worry)
Weak or interrupted flow of urine
Weakened immune system
Weakened immune system (e.g., due to HIV, immunosuppressant medications)
Weakened immune system (e.g., due to HIV/AIDS or organ transplant medicines)
Weakened immune systems
Weakened immune systems due to HIV/AIDS
Weakened immune systems due to immunosuppressive medications after organ transplant
Weakness in face
Weakness or feeling tired
Weakness or paralysis
Wedge resection
Weight gain (Cushing's syndrome)
Weight loss (in males)
Weight loss (rare, constitutional symptom)
Weight loss for no known reason
Weight loss for no reason
Weiss system scoring (pathology)
Well-differentiated astroblastoma
Well-differentiated neuroendocrine carcinomas (low-grade malignant)
Well-differentiated neuroendocrine tumors (low grade, uncertain behavior)
White ethnicity
White or red patch in the mouth
White or yellow coating on tonsils
White people
White racial/ethnic group
Whitish appearance
Whitish or yellowish glow through the pupil (leukocoria)
Whitish, translucent mass in the eye
WHO diagnostic grading criteria
WHO Grade III Ependymoma
WHO type 1: squamous cell carcinoma
WHO type 2: non-keratinizing carcinoma
WHO type 3: undifferentiated carcinoma
Widespread distribution of germ cells to multiple sites during normal embryogenesis
Wilson's disease (controversial)
WISP3
Wnt pathway inhibitors (e.g., E7386, tegavivint, ipafricept, investigational)
Wnt signaling pathway alterations
WNT/β-catenin
WNT/β-catenin pathway activation
Working in buildings containing asbestos
Working in petroleum refining or rubber manufacturing
Working with asbestos-containing materials
Worsening constipation
X-LAG syndrome
X-rays (sunburst appearance, Codman triangle)
Xp11 translocation carcinomas
Yellow skin (jaundice, liver metastases)
Yellowing of eyes
Yellowing of the skin
Yellowing of the skin (jaundice)
Yellowing of the skin and eyes (jaundice)
Yellowing of the skin and whites of the eyes
Yellowish skin
Yolk sac tumor (endodermal sinus tumor)
Yolk sac tumor (endodermal sinus tumors)
Young age (for retinoblastoma)
Young age (infants and young children)
Young age (most common in 15-19 year old women, 75% incidence rate for women <30 years)
Young age (under 25 years)
Young age (under 3 years old)
Young age at time of radiation exposure
Young males (for diagnosis consideration)
Young people (for astrocytomas in the base of the brain)
Younger age (in children)
Younger age (multiple glomus tumors develop earlier)
Younger age at diagnosis for African-Americans
Younger children (for viral tonsillitis)